Anxiety disorders, excluding more controls

KRA_PSY_ANXIETY_EXMORE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F40-F48 Hospital discharge: ICD-9 — 300[0-3\|6-9]\|3078A\|309 Hospital discharge: ICD-8 — 300[0-2]\|30030\|300[5-9]\|305\|30680\|30799 Cause of death: ICD-10 — F40-F48 Cause of death: ICD-9 — 300[0-3\|6-9]\|3078A\|309 Cause of death: ICD-8 — 300[0-2]\|30030\|300[5-9]\|305\|30680\|30799 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: KRA_PSY_ANYMENTAL

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	KRA_PSY_ANXIETY_EXMORE
CONTROL_EXCLUDE	KRA_PSY_ANYMENTAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F4
HD_ICD_9	300[0-3\|6-9]\|3078A\|309
HD_ICD_8	300[0-2]\|30030\|300[5-9]\|305\|30680\|30799
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F4
COD_ICD_9	300[0-3\|6-9]\|3078A\|309
COD_ICD_8	300[0-2]\|30030\|300[5-9]\|305\|30680\|30799
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Anxiety disorders, excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	534702	319646	211486
Only index persons	494695	301970	192725
Unadjusted period prevalence (%)
Whole population	7.84	9.16	5.91
Only index persons	9.64	11.10	7.36
Median age at first event (years)
Whole population	31.24	32.68	28.98
Only index persons	30.42	31.83	28.21

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	59081	40895	18186
Unadjusted period prevalence (%)	12.12	13.94	8.02
Median age at first event (years)	36.61	36.04	37.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
29925: Matched controls
227058

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

323.0

3977

14288

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

1337.0

323.0

503

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.8

323.0

1443

2378

R06.0

ICD-10 Finland

Dyspnoea

2.1

323.0

7305

30705

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

60.2

323.0

1720

230

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

108.2

323.0

1166

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

323.0

11027

58312

N05BE01

ATC

buspirone; oral

22.4

323.0

1995

723

A02BA02

ATC

ranitidine; systemic

2.0

323.0

6063

25162

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

323.0

17516

105308

N06AX03

ATC

mianserin; oral

10.2

323.0

2606

2096

N06AA04

ATC

clomipramine; systemic

14.3

323.0

1072

590

N06AB05

ATC

paroxetine; oral

8.5

323.0

3396

3373

N06AX21

ATC

duloxetine; oral

6.4

323.0

5440

7584

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

944.9

323.0

965

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

88.3

323.0

4413

444

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

323.0

14076

75698

F33

ICD-10 Finland

Recurrent depressive disorder

16.0

323.0

641

311

30088

ICD-8 Finland

Neuroses, Other

+∞

323.0

555

N05AN01

ATC

lithium; oral

85.9

323.0

1228

113

N05CF02

ATC

zolpidem; oral

2.8

323.0

6469

20152

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

132.5

323.0

1399

F45.8

ICD-10 Finland

Other somatoform disorders

5.9

323.0

2970

4154

S06.0

ICD-10 Finland

Concussion

2.7

323.0

2962

8818

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3297.0

323.0

436

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

34.6

323.0

6364

1756

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

1573.6

323.0

424

F43.2

ICD-10 Finland

Adjustment disorders

11.4

323.0

690

471

P76

ICPC

Depressive disorder

12.8

323.0

2755

1779

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

+∞

323.0

1036

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

84.2

323.0

1276

120

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

416.8

323.0

541

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

582.9

323.0

677

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.3

323.0

1468

2672

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

34.1

323.0

3442

862

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2773.1

323.0

729

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

265.9

323.0

554

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2215.1

323.0

874

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

741.7

323.0

763

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

+∞

323.0

444

A28

ICPC

Limited function/disability NOS

2.3

323.0

3637

13059

F60.5

ICD-10 Finland

Anankastic personality disorder

78.0

323.0

535

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

125.1

323.0

896

L28

ICPC

Limited function/disability (L)

2.2

323.0

4264

15807

F31.8

ICD-10 Finland

Other bipolar affective disorders

321.1

323.0

827

A01

ICPC

Pain general/multiple sites

2.9

323.0

2378

6485

F22.0

ICD-10 Finland

Delusional disorder

132.7

323.0

667

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.8

323.0

2451

6976

N05BA01

ATC

diazepam; systemic, rectal

6.0

323.0

6884

10718

P74

ICPC

Anxiety disorder/anxiety state

15.6

323.0

1532

782

N03AG01

ATC

valproic acid; systemic, rectal

12.0

323.0

2877

2002

N06AB04

ATC

citalopram; systemic

7.6

323.0

11479

17098

R03AC02

ATC

salbutamol; inhalant

1.7

323.0

14956

83159

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

323.0

10929

45745

N06AX26

ATC

vortioxetine; oral

10.3

323.0

2393

1901

N05BA12

ATC

alprazolam; oral

6.5

323.0

5761

8071

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

197.9

323.0

487

N05AA02

ATC

levomepromazine; systemic

39.9

323.0

2654

552

IGY02

NOMESCO Finland

Psychiatric monitoring contact

142.6

323.0

982

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

2907.6

323.0

386

N06AB03

ATC

fluoxetine; oral

6.9

323.0

6499

8723

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.1

323.0

2761

7222

F41.09

ICD-10 Finland

UNS Panic Syndrome

38.6

323.0

1877

393

AA400

NOMESCO Finland

Electroconvulsive therapy

840.4

323.0

437

IGY99

NOMESCO Finland

Other psychiatric treatment contact

138.0

323.0

745

N03AE01

ATC

clonazepam; systemic

7.2

323.0

3061

3535

N07BB01

ATC

disulfiram; oral

12.7

323.0

2242

1442

F29

ICD-10 Finland

Unspecified nonorganic psychosis

285.5

323.0

1681

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

16.5

323.0

4827

2609

R42

ICD-10 Finland

Dizziness and giddiness

2.1

323.0

6269

25693

F41.3

ICD-10 Finland

Other mixed anxiety disorders

32.7

323.0

588

139

SPAT1307

SPAT

Psychosocial counselling and guidance

7.3

323.0

1626

1765

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

795.5

323.0

414

F61.0

ICD-10 Finland

Mixed personality disorders

369.6

323.0

1220

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

51.5

323.0

4888

857

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

62.9

323.0

1549

197

M54.5

ICD-10 Finland

Low back pain

2.1

323.0

10019

44616

F32.8

ICD-10 Finland

Other depressive episodes

31.3

323.0

616

152

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

265.7

323.0

956

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

392.9

323.0

907

F43.00

ICD-10 Finland

Acute stress reaction mild

13.0

323.0

1336

812

N06AX16

ATC

venlafaxine; oral

10.2

323.0

7956

7782

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

22.0

323.0

1132

405

A02BC02

ATC

pantoprazole; systemic

2.0

323.0

19697

112260

F41.00

ICD-10 Finland

Moderate panic disorder

225.1

323.0

1192

SPAT1254

SPAT

Administration of medicine

2.4

323.0

3951

13436

N06AB10

ATC

escitalopram; oral

6.5

323.0

9197

14591

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

25.1

323.0

2014

651

N05BA04

ATC

oxazepam; oral

6.7

323.0

12473

21736

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

323.0

572

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

323.0

7946

38014

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

323.0

6287

27387

N06AB06

ATC

sertraline; oral

9.5

323.0

5715

5518

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.2

323.0

4140

10847

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

818.0

323.0

1142

C07AA05

ATC

propranolol; systemic

3.3

323.0

7440

20529

SPAT1234

SPAT

Support of social functional capacity

4.3

323.0

1376

2533

F41.1

ICD-10 Finland

Generalized anxiety disorder

46.2

323.0

3360

619

N06AA12

ATC

doxepin; systemic

7.2

323.0

2684

3062

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

15.1

323.0

943

487

F10.20

ICD-10 Finland

Alcohol dependence currently independent

116.1

323.0

1247

N05CD07

ATC

temazepam; oral

5.4

323.0

5639

9305

F41.8

ICD-10 Finland

Other specified anxiety disorders

18.8

323.0

1182

495

M79.6

ICD-10 Finland

Pain in limb

1.9

323.0

10635

50889

N05AA01

ATC

chlorpromazine; systemic, rectal

110.6

323.0

656

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

323.0

4785

18638

SPAT1240

SPAT

Therapeutic discussion

6.8

323.0

4177

5268

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

287.6

323.0

852

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.1

323.0

4381

9150

Z71.8

ICD-10 Finland

Other specified counselling

2.0

323.0

6532

27722

N06AG02

ATC

moclobemide; oral

8.5

323.0

2309

2214

P29

ICPC

Psychological sympt/compl other

11.2

323.0

2246

1627

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

517.7

323.0

603

N05AF05

ATC

zuclopenthixol; systemic

250.3

323.0

458

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

323.0

676

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

+∞

323.0

551

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

103.9

323.0

4399

376

N05AX12

ATC

aripiprazole; systemic

250.2

323.0

1700

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

323.0

8544

36657

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.3

323.0

1909

4571

T36

ICD-10 Finland

Poisoning by systemic antibiotics

69.2

323.0

2609

313

N03AX09

ATC

lamotrigine; oral

17.9

323.0

2284

1044

R51.80

ICD-10 Finland

Headache

2.7

323.0

4524

13987

F10.09

ICD-10 Finland

Alcohol intoxication UNS

159.6

323.0

819

N05AX08

ATC

risperidone; systemic

29.6

323.0

3492

1008

F32.9

ICD-10 Finland

Depressive episode, unspecified

34.2

323.0

7474

2186

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

323.0

20343

121011

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.7

323.0

14828

84262

N06AA09

ATC

amitriptyline; systemic

4.3

323.0

4456

8940

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

323.0

4503

16708

R53

ICD-10 Finland

Malaise and fatigue

2.9

323.0

6440

19501

N03AX16

ATC

pregabalin; oral

2.8

323.0

9017

29844

N05AH04

ATC

quetiapine; oral

16.4

323.0

9641

6385

P16

ICPC

Acute alcohol abuse

16.1

323.0

617

297

N05BA06

ATC

lorazepam; systemic, sublingual

10.0

323.0

2516

2062

F32

ICD-10 Finland

Depressive episode

7.8

323.0

1903

1958

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

100.6

323.0

1464

116

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

+∞

323.0

467

N03AF01

ATC

carbamazepine; oral, rectal

4.0

323.0

1852

3682

N02AX02

ATC

tramadol; systemic, rectal

1.9

323.0

13177

65805

F99

ICD-10 Finland

Mental disorder, not otherwise specified

136.8

323.0

960

F43.1

ICD-10 Finland

Post-traumatic stress disorder

40.6

323.0

1298

253

P15

ICPC

Chronic alcohol abuse

15.4

323.0

1200

614

R11

ICD-10 Finland

Nausea and vomiting

2.9

323.0

2242

6123

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

16350.3

323.0

2019

SPAT1243

SPAT

Psychiatric/psychological examination

10.2

323.0

774

587

F43.29

ICD-10 Finland

Adaptation disorder UNS

33.8

323.0

1555

367

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

85.2

323.0

2504

243

R52.2

ICD-10 Finland

Other chronic pain

4.7

323.0

1294

2164

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

283.4

323.0

371

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

831.4

323.0

644

N06AX05

ATC

trazodone; oral

15.3

323.0

1275

657

N05AC02

ATC

thioridazine; oral

50.3

323.0

946

147

N06AX22

ATC

agomelatine; oral

17.5

323.0

940

419

F10.24

ICD-10 Finland

Alcohol depence active use

87.8

323.0

701

K02.1

ICD-10 Finland

Caries of dentine

1.8

323.0

16078

89242

F10.25

ICD-10 Finland

Alcohol dependence continuous use

101.7

323.0

847

N05AL01

ATC

sulpiride; systemic

17.3

323.0

754

338

F60.9

ICD-10 Finland

Personality disorder, unspecified

810.8

323.0

832

A04

ICPC

Weakness/tiredness general

2.7

323.0

3457

10634

WX110

NOMESCO Finland

Local anesthesy

1.8

323.0

19643

117700

P01

ICPC

Feeling anxious/nervous/tense

8.9

323.0

3806

3670

N05AH02

ATC

clozapine; systemic

887.8

323.0

798

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

13.7

323.0

1083

622

N04AA02

ATC

biperiden; systemic

46.8

323.0

927

155

N05AB01

ATC

dixyrazine; systemic

22.4

323.0

647

224

F40.1

ICD-10 Finland

Social phobias

76.6

323.0

1452

151

F43.8

ICD-10 Finland

Other reactions to severe stress

8.7

323.0

838

748

A02BC05

ATC

esomeprazole; systemic

1.8

323.0

12315

64477

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

55.0

323.0

1110

159

N02BE01

ATC

paracetamol; systemic, rectal

1.9

323.0

24850

163902

N05CF01

ATC

zopiclone; oral

3.6

323.0

12771

39006

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

707.5

323.0

993

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

110.1

323.0

415

N05AF03

ATC

chlorprothixene; systemic

81.8

323.0

1594

156

A02BC03

ATC

lansoprazole; oral

1.9

323.0

8931

42361

A06AD11

ATC

lactulose; oral

2.8

323.0

4312

12698

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.6

323.0

2421

5370

F43.01

ICD-10 Finland

Acute stress reaction moderate

12.7

323.0

689

420

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

+∞

323.0

437

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

1416.2

323.0

572

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

323.0

410

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

173.8

323.0

1146

P99

ICPC

Psychological disorders other

30.6

323.0

1204

310

KMAK

NOMESCO Finland

1.6

323.0

14214

81503

N05AD01

ATC

haloperidol; systemic

12.2

323.0

1132

727

N06AX12

ATC

bupropion; oral

14.8

323.0

2864

1610

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

45.9

323.0

3274

606

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

1597.2

323.0

641

F45.0

ICD-10 Finland

Somatization disorder

102.2

323.0

399

EBA00

NOMESCO Finland

Extraction of tooth

1.9

323.0

9114

43241

AA1AD

NOMESCO Finland

CT of head and brain

2.2

323.0

6990

27319

30799

ICD-8 Finland

Transient situational disturbances

+∞

323.0

355

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

250.0

323.0

776

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

176.4

323.0

682

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

184.8

323.0

550

N06AB08

ATC

fluvoxamine; oral

9.9

323.0

1468

1179

N05AF01

ATC

flupentixol; systemic

16.2

323.0

890

429

F51.0

ICD-10 Finland

Nonorganic insomnia

4.0

323.0

4720

10066

P03

ICPC

Feeling depressed

8.0

323.0

3355

3518

G44.2

ICD-10 Finland

Tension-type headache

2.5

323.0

4079

13518

P06

ICPC

Sleep disturbance

2.9

323.0

3022

8457

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

323.0

7247

31927

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

825.8

323.0

847

F34.1

ICD-10 Finland

Dysthymia

63.5

323.0

2247

290

P72

ICPC

Schizophrenia

123.8

323.0

748

A02BC01

ATC

omeprazole; systemic

1.9

323.0

8033

37012

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

102.9

323.0

818

N05AH03

ATC

olanzapine; systemic

79.7

323.0

3541

382

F90.0

ICD-10 Finland

Disturbance of activity and attention

21.5

323.0

526

189

N05AD03

ATC

melperone; systemic

30.0

323.0

545

140

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

171.8

323.0

3253

161

N03AX12

ATC

gabapentin; oral

2.9

323.0

5752

17463

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

515.7

323.0

666

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2322.2

323.0

914

N05AB03

ATC

perphenazine; systemic, rectal

41.9

323.0

2023

392

N06AA06

ATC

trimipramine; systemic

9.0

323.0

1182

1033

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

323.0

11611

59313

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

28.0

323.0

5910

1980

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

323.0

480

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

323.0

12110

65986

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.0

323.0

8162

36562

F31

ICD-10 Finland

Bipolar affective disorder

112.6

323.0

482

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

+∞

323.0

603

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

323.0

5465

22641

F39

ICD-10 Finland

Unspecified mood [affective] disorder

52.0

323.0

684

102

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

323.0

16200

91375

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

239.3

323.0

704

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

774.0

323.0

403

188

Kela drug reimbursment

Psychosis requiring demanding treatment

1709.9

323.0

459

M79.7

ICD-10 Finland

Fibromyalgia

5.0

323.0

1197

1860

V03AA01

ATC

13.2

323.0

766

450

L03

ICPC

Low back symptom/complaint

1.9

323.0

6733

29828

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

119.9

323.0

3456

247

N05BA02

ATC

chlordiazepoxide; systemic

14.2

323.0

1232

684

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

323.0

8884

38648

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.6

323.0

2503

5569

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

323.0

4905

19858

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

380.7

323.0

1347

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

323.0

636

F32.1

ICD-10 Finland

Moderate depressive episode

12.4

323.0

2112

1377

WX290

NOMESCO Finland

Other blockade of nerve

1.8

323.0

12070

63152

N06AX11

ATC

mirtazapine; oral

5.9

323.0

14953

32697

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

49.8

323.0

1010

159

P01AB01

ATC

metronidazole; oral, rectal

1.7

322.7

11106

59632

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

322.2

9188

46744

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

321.3

16054

95106

F60.8

ICD-10 Finland

Other specific personality disorders

542.6

320.9

354

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

320.3

3820

14125

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

320.1

342

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

317.1

4883

20122

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

14.8

316.9

584

305

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

30.7

315.3

463

116

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

312.8

7848

38336

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.1

312.1

4146

16066

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

+∞

308.8

330

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.3

308.6

3201

11059

M79.1

ICD-10 Finland

Myalgia

2.2

307.4

3661

13509

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

171.3

307.3

357

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

306.1

6864

32315

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

+∞

305.1

326

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

33.2

305.0

440

102

J02AC01

ATC

fluconazole; systemic

1.6

304.8

10750

57842

C07AB07

ATC

bisoprolol; oral

1.6

304.4

12827

72326

J01DA01

ATC

[U] cefalexin; systemic

1.6

304.2

17592

107429

F61

ICD-10 Finland

Mixed and other personality disorders

322.8

301.1

338

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

71.2

300.7

380

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

321.8

300.2

337

N02AA05

ATC

oxycodone; systemic

2.1

296.6

3943

15255

30680

ICD-8 Finland

Special symptoms not elsewhere classified, Cephalalgia

+∞

295.7

316

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

295.6

5729

25634

XA800

NOMESCO Finland

Neuropsychological investigation

3.9

293.4

1349

2705

30180

ICD-8 Finland

Personality disorders, Immatura

+∞

292.9

313

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

292.5

4892

20744

G47.3

ICD-10 Finland

Sleep apnoea

1.8

292.3

6415

29918

F60.7

ICD-10 Finland

Dependent personality disorder

608.7

289.2

318

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

+∞

289.1

309

M03BX02

ATC

tizanidine; oral

1.6

285.9

18088

112040

M25.5

ICD-10 Finland

Pain in joint

1.7

285.8

7989

40094

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

285.7

7171

34849

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

284.0

4523

18801

J01DB01

ATC

cefalexin; oral

1.7

283.0

23150

152863

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

+∞

281.6

301

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

280.5

5933

27278

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

280.0

10288

55603

R52.9

ICD-10 Finland

Pain, unspecified

2.5

278.9

2504

8000

L17

ICPC

Foot/toe symptom/complaint

1.7

278.2

6754

32442

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

+∞

277.9

297

-1

NOMESCO Finland

1.7

277.6

8738

45276

N06AX18

ATC

reboxetine; oral

13.2

277.4

535

312

N01

ICPC

Headache

2.5

273.9

2367

7402

F33.8

ICD-10 Finland

Other recurrent depressive disorders

75.0

272.5

342

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2179.2

270.8

292

D11

ICPC

Diarrhoea

2.3

270.5

2786

9553

SPAT1263

SPAT

Sampling

1.6

268.3

10977

60790

N06BA04

ATC

methylphenidate; oral

16.7

267.2

470

217

F40.2

ICD-10 Finland

Specific (isolated) phobias

49.6

267.1

356

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

265.4

12991

75094

30188

ICD-8 Finland

Personality disorders, Alia definita

+∞

264.8

283

R07.3

ICD-10 Finland

Other chest pain

2.3

264.0

2777

9615

F41.01

ICD-10 Finland

Severe panic disorder

179.8

263.5

305

3092D

ICD-9 Finland

Adjustment reaction, With predominant disturbance of other emotions[AHDISTUNEISUUTENA ILMENEVÄ SOPEUTUMISHÄIRIÖ]

+∞

262.9

281

K59.0

ICD-10 Finland

Constipation

3.2

261.0

1582

3948

K59.09

ICD-10 Finland

Constipation, unspecified

2.9

260.3

1748

4681

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

138.4

260.2

307

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

260.1

4310

18127

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

260.1

278

30099

ICD-8 Finland

Neuroses, Unspecified neurosis

+∞

259.1

277

SPAT1216

SPAT

Assessment of functional ability

2.0

258.4

3833

15443

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

5.9

257.5

793

1034

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

256.7

4739

20720

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

254.5

5455

25082

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

203.8

254.2

292

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

12.9

253.8

495

296

SPAT1301

SPAT

No procedures

1.6

253.7

7978

41104

F21

ICD-10 Finland

Schizotypal disorder

1066.3

253.7

276

R74

ICPC

Upper respiratory infection acute

1.7

253.7

6740

33110

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.4

251.4

2434

8074

N06AX17

ATC

milnacipran; oral

11.8

249.9

507

331

R21

ICPC

Throat symptom/complaint

1.9

249.9

4404

18919

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

249.8

267

L01

ICPC

Neck symptom/complaint

2.0

248.4

3657

14668

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

248.4

5036

22707

P25

ICPC

Phase of life problem adult

4.2

248.2

1040

1909

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

246.9

7671

39337

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

239.9

245.9

280

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

245.5

10601

59111

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

94.8

243.2

297

H02AB06

ATC

prednisolone; systemic

1.5

243.1

12698

73969

R02

ICPC

Shortness of breath/dyspnoea

2.1

242.9

3163

12053

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

242.2

5512

25779

UJF32

NOMESCO Finland

Coloscopy

1.7

241.5

7084

35712

SPAT1246

SPAT

Screening of depression or other psychiatric problem

5.6

240.8

781

1086

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

79.0

239.8

299

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

143.4

238.9

281

F43.0

ICD-10 Finland

Acute stress reaction

3.6

238.4

1205

2613

B18.2

ICD-10 Finland

Chronic viral hepatitis C

16.1

238.3

424

202

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

238.0

2494

8597

IGV01

NOMESCO Finland

Psychiatric network contact

1893.9

236.2

255

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

235.1

2065

6492

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

233.7

11537

66142

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

492.6

233.3

258

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

233.0

2988

11298

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

186.5

232.1

268

R06AE07

ATC

cetirizine; oral

1.5

231.6

11529

66178

Z72.1

ICD-10 Finland

Alcohol use

13.7

230.7

438

246

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

644.4

230.4

253

P28

ICPC

Limited function/disability (P)

35.7

229.9

326

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.6

228.6

1167

2550

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

227.9

9906

55047

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

479.1

226.8

251

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

+∞

226.3

242

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

+∞

226.3

242

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

220.4

225.6

258

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

1801.5

224.9

243

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

1793.8

224.0

242

F20.0

ICD-10 Finland

Paranoid schizophrenia

1793.8

224.0

242

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.9

223.7

1039

2095

30530

ICD-8 Finland

Physical disorders of presumably psychogenic origin, Cardiovascular

+∞

223.5

239

3092E

ICD-9 Finland

Adjustment reaction, With predominant disturbance of other emotions[USEINA EMOTIONAALISINA OIREINA ILM.SOPEUTUMISHÄIRIÖ]

+∞

223.5

239

F32.0

ICD-10 Finland

Mild depressive episode

6.2

222.5

666

836

J01FF01

ATC

clindamycin; systemic

1.6

222.3

7359

38169

30050

ICD-8 Finland

Neuroses, Neurasthenia

+∞

221.7

237

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

+∞

221.7

237

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

+∞

221.7

237

H03AA01

ATC

levothyroxine sodium; systemic

1.7

220.9

6225

30900

P27

ICPC

Fear of mental disorder

18.5

220.8

374

155

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

1755.3

219.3

237

N05CD02

ATC

nitrazepam; oral

6.7

218.3

612

702

D01

ICPC

Abdominal pain/cramps general

2.2

218.1

2629

9657

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

216.6

7892

41892

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

216.2

2137

7139

Z00.0

ICD-10 Finland

General medical examination

1.8

216.0

4730

21755

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

95.8

215.7

263

K07.60

ICD-10 Finland

Snapping jaw

3.1

215.7

1355

3459

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.5

215.6

1906

6003

WZA90

NOMESCO Finland

Other doctors statement

1.7

215.5

5960

29399

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

215.4

5913

29104

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

215.2

2765

10444

F20

ICD-10 Finland

Schizophrenia

600.7

214.5

236

Z01.2

ICD-10 Finland

Dental examination

1.5

213.9

10701

61153

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

213.6

3870

16702

N03AX11

ATC

topiramate; oral

5.1

212.1

741

1124

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

+∞

210.4

225

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

19.0

209.7

352

142

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

209.3

12316

72787

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

184.3

208.6

241

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

296.7

207.8

234

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.1

207.0

1277

3217

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

154.2

206.9

242

N05AE04

ATC

ziprasidone; systemic

295.4

206.8

233

E0000UV

ATC

1.5

206.3

10083

57194

N30.0

ICD-10 Finland

Acute cystitis

1.9

204.7

3293

13595

A03FA02

ATC

cisapride; oral, rectal

2.3

204.5

2234

7831

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

78.0

204.3

255

A03CA02

ATC

clidinium and psycholeptics; oral

2.5

203.6

1833

5825

IEY01

NOMESCO Finland

Psychoeducation, individual

199.1

203.5

234

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.0

202.6

2980

11883

R05

ICPC

Cough

1.7

202.5

5593

27508

C03CA01

ATC

furosemide; systemic

1.6

201.9

6577

33817

Z08

ICPC

Social welfare problem

9.6

201.2

452

362

L02

ICPC

Back symptom/complaint

2.2

200.7

2301

8247

F60.0

ICD-10 Finland

Paranoid personality disorder

1601.6

200.6

217

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

200.1

3411

14377

K30

ICD-10 Finland

Functional dyspepsia

2.0

199.7

2895

11472

P98

ICPC

Psychosis NOS/other

161.2

199.0

232

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

198.8

3163

12996

F41

ICD-10 Finland

Other anxiety disorders

8.9

198.6

464

399

30010

ICD-8 Finland

Neuroses, Hysterical neurosis

+∞

198.2

212

R03BB04

ATC

tiotropium bromide; inhalant

2.1

198.1

2461

9144

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

197.7

3217

13327

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

137.0

197.5

233

P20

ICPC

Memory disturbance

2.2

197.3

2401

8837

F05.9

ICD-10 Finland

Delirium, unspecified

7.7

197.3

504

503

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

196.8

3272

13659

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

196.6

2885

11483

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

+∞

196.4

210

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

8.9

195.9

460

399

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

195.7

7192

38071

R13

ICD-10 Finland

Dysphagia

2.5

195.2

1789

5739

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

195.1

4239

19382

IBA03

NOMESCO Finland

Psychotherapy evaluation

546.7

195.0

215

P18

ICPC

Medication abuse

55.6

194.3

254

3009X

ICD-9 Finland

Neurotic disorders, Unspecified neurotic disorder

+∞

193.6

207

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

1532.5

192.2

208

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.9

191.6

875

1736

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

191.5

1599

4872

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.5

191.3

1719

5454

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

+∞

190.8

204

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

1517.2

190.4

206

SPAT1310

SPAT

Counselling related to known health issue

1.5

190.2

7881

42868

R4140

NOMESCO Finland

Psychotherapy

60.5

189.8

245

F20.5

ICD-10 Finland

Residual schizophrenia

+∞

188.9

202

F03

ICD-10 Finland

Unspecified dementia

7.5

188.6

490

502

N03AF02

ATC

oxcarbazepine; oral

3.7

188.4

912

1903

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

188.1

10014

57541

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

188.1

2583

10001

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

1494.2

187.6

203

N05BA05

ATC

potassium clorazepate; oral

10.0

185.9

409

315

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

1478.8

185.7

201

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

+∞

185.1

198

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

185.0

1939

6653

T74.1

ICD-10 Finland

Physical abuse

6.7

184.2

518

597

Z02.7

ICD-10 Finland

Issue of medical certificate

2.6

183.6

1540

4700

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

182.6

8616

48162

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

+∞

182.3

195

R41.0

ICD-10 Finland

Disorientation, unspecified

4.7

182.0

689

1140

J01FA06

ATC

roxithromycin; oral

1.5

181.3

10890

64009

J01EA01

ATC

trimethoprim; systemic

1.6

180.5

6087

31428

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

180.4

3199

13637

P02

ICPC

Acute stress reaction

3.4

177.8

979

2266

3000C

ICD-9 Finland

Neurotic disorders, Anxiety states[YLEISTYNYT TUSKAISUUS]

+∞

177.6

190

M54.2

ICD-10 Finland

Cervicalgia

2.2

176.3

1966

6941

S18

ICPC

Laceration/cut

1.4

176.2

10949

64681

J01CA08

ATC

pivmecillinam; oral

1.5

176.0

9404

53875

R4110

NOMESCO Finland

Physiotherapy

1.5

176.0

7033

37803

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

9.2

175.8

403

335

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

175.8

2142

7873

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

192.0

174.5

201

IHZ05

SPAT

10.0

174.4

383

294

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

13.3

173.9

334

193

N06AA10

ATC

nortriptyline; systemic

4.3

173.9

710

1268

SPAT1283

SPAT

Restricted health certificate

1.8

173.4

3509

15633

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.5

173.1

1485

4587

3000B

ICD-9 Finland

Neurotic disorders, Anxiety states[PANIIKKIHÄIRIÖ]

+∞

173.0

185

29599

ICD-8 Finland

Schizophrenia, Unspecified type

+∞

173.0

185

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

+∞

173.0

185

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

6.3

172.9

506

616

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.6

172.9

1367

4031

X78

ICD-10 Finland

Intentional self-harm by sharp object

+∞

172.0

184

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

1363.9

171.7

186

SPAT1260

SPAT

Consultation of another employee

1.7

171.4

4374

20913

SPAT1265

SPAT

Breathalyser

12.9

171.3

333

198

N17

ICPC

Vertigo/dizziness

1.9

170.9

2682

10923

P80

ICPC

Personality disorder

77.5

170.7

213

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

170.6

7095

38435

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.7

170.2

1324

3866

29580

ICD-8 Finland

Schizophrenia, Other

+∞

170.2

182

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

170.1

4107

19317

M01AE02

ATC

naproxen; oral, rectal

1.4

170.1

15128

95407

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.5

169.9

1494

4677

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

80.2

169.0

210

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

118.1

168.3

201

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

167.7

5612

28844

A02BA04

ATC

nizatidine; systemic

2.1

166.4

2158

8139

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

166.3

3028

13006

R00.2

ICD-10 Finland

Palpitations

2.2

166.0

1882

6688

SPAT1241

SPAT

Extensive assessment of psychosocial situation

12.6

165.8

325

197

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

165.4

5279

26794

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

165.0

1192

3325

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

115.7

164.7

197

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

+∞

163.6

175

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

163.2

3903

18286

R55

ICD-10 Finland

Syncope and collapse

2.0

162.7

2533

10273

P58

ICPC

Psychological, Therapeutic counselling/listening

7.5

162.6

422

432

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.3

162.3

1669

5662

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

162.0

6296

33508

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

2.1

161.6

1985

7310

A01AB09

ATC

miconazole; local oral

2.0

161.5

2341

9235

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.9

160.7

1117

3041

F43.23

ICD-10 Finland

Adaptive disorder with other mental disorder

33.2

159.9

230

R50.9

ICD-10 Finland

Fever, unspecified

1.8

159.7

3330

14947

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

159.5

2627

10877

R1250

NOMESCO Finland

Evaluation of functional capability

4.1

159.0

678

1262

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

158.8

18196

119367

J01AA02

ATC

doxycycline; systemic

1.4

158.6

22072

150070

E66.8

ICD-10 Finland

Other obesity

2.5

158.5

1340

4102

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

158.1

2744

11575

F43.02

ICD-10 Finland

Acute stress reaction severe

29.7

157.8

233

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

157.8

2113

8070

A07AA02

ATC

nystatin; oral

2.3

157.7

1710

5949

N06AA22

ATC

13.9

157.7

297

164

IER01

NOMESCO Finland

Psychoeducation, group

1352.2

157.7

171

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

3.3

157.4

872

2026

SPAT1252

SPAT

Overall medication plan or its review

2.2

157.4

1719

6000

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

+∞

157.1

168

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

156.4

2048

7748

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

156.2

2837

12159

29999

ICD-8 Finland

Unspecified psychosis

+∞

156.1

167

F60.2

ICD-10 Finland

Dissocial personality disorder

1334.3

155.8

169

TAB00

NOMESCO Finland

Lumbar puncture

2.8

155.6

1111

3076

K08.3

ICD-10 Finland

Retained dental root

2.2

155.6

1808

6494

J01MA12

ATC

levofloxacin; systemic

1.6

154.1

4642

23158

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.0

154.0

1015

2668

W19

ICD-10 Finland

Unspecified fall

2.0

153.8

2240

8848

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

153.7

2802

12020

SPAT1229

SPAT

Assessment of need for aid

2.1

152.5

1911

7094

N05AC01

ATC

periciazine; systemic

31.4

152.4

222

30020

ICD-8 Finland

Neuroses, Phobic neurosis

+∞

152.4

163

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

+∞

152.4

163

R35

ICD-10 Finland

Polyuria

2.3

151.7

1562

5297

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

151.4

2843

12315

J01CA04

ATC

amoxicillin; systemic

1.4

151.3

21824

148488

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

150.9

13239

82550

R01AD09

ATC

mometasone; nasal

1.4

150.8

11641

70963

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

12.4

150.5

297

183

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

150.4

1675

5896

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

149.5

4306

21209

J01MA02

ATC

ciprofloxacin; systemic

1.4

149.3

9955

59053

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

5.3

149.2

504

735

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

149.1

1180

3477

E000001

ATC

1.6

149.0

4862

24732

S29

ICPC

Skin symptom/complaint other

1.7

148.8

4070

19764

N04BC05

ATC

pramipexole; oral

2.1

148.5

1928

7261

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

147.6

4758

24123

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

413.4

146.7

163

Z29

ICPC

Social problem NOS

5.8

146.3

458

609

A11

ICPC

Chest pain NOS

2.1

146.3

1944

7394

P73

ICPC

Affective psychosis

144.9

145.7

171

L12

ICPC

Hand/finger symptom/complaint

1.7

145.5

3438

16003

SPAT1227

SPAT

Substance abuse rehabilitation

18.2

145.3

247

104

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

143.9

6680

36821

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

247.0

143.6

163

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5402

20482

1.84

319.88

2.6

2.3

0.2

g/l

5.25

4962

19342

(3024354) Oxygen [Partial pressure] in Venous blood

4351

15462

1.95

313.27

4.1

3.2

4.8

4.6

kpa

4.94

4177

15037

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7342

30682

1.68

310.27

2.7

2.5

22.6

23.3

3.83

6343

26450

(3002385) Erythrocyte distribution width [Ratio]

39504

234165

1.52

307.80

20.9

13.7

13.6

1.88

38881

229213

(36304419) Bacteria [Presence] in Urine

14677

64266

1.72

307.65

3.4

2.8

—

(3027008) Opiates [Presence] in Urine

5444

9454

4.15

307.65

3.0

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5221

18992

1.92

307.65

4.7

3.9

5.9

5.8

kpa

11.68

5036

18533

(3017143) Hepatitis C virus Ab [Presence] in Serum

8574

32687

1.89

307.65

1.8

1.6

—

(3016879) Cocaine [Presence] in Urine

5260

8345

4.54

307.65

3.1

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8650

37289

1.65

307.65

3.1

2.7

4.0

2.9

e6/l

6.87

4483

19883

(3022948) Iron [Moles/volume] in Serum or Plasma

8674

36020

1.72

307.65

2.6

2.4

13.5

14.2

umol/l

0.61

8019

33648

(3037467) Urinalysis macro (dipstick) panel - Urine

34037

180804

1.74

307.65

5.1

3.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

25041

115581

1.85

307.65

3.3

2.7

103.5

116.0

ug/l

7.30

23327

108568

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

10820

36695

2.21

307.65

2.5

2.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

6243

20901

2.12

307.65

2.3

1.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1019

852

8.07

307.65

1.8

1.1

1.5

1.0

promille

13.99

763

681

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6217

22965

1.90

307.65

1.9

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6175

22842

1.90

307.65

1.9

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

24442

130136

1.47

307.65

5.5

4.4

0.0

estimate

0.16

4960

24486

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

7096

27019

1.86

307.65

2.8

2.7

6.7

8.1

umol/l

7.20

5900

23764

(3048689) Calprotectin [Mass/mass] in Stool

8718

33244

1.89

307.65

2.4

2.5

120.2

132.7

ug/g

2.34

6698

26582

(46235355) HIV 1 and 2 tests - Meaningful Use set

13725

57104

1.81

307.65

2.2

1.9

—

(3019069) Monocytes/100 leukocytes in Blood

25868

121145

1.84

307.65

7.4

6.0

8.3

8.5

23.05

24290

114206

(42870588) Differential panel, method unspecified - Blood

19448

84493

1.85

307.65

6.6

5.9

—

(3033658) Prothrombin time (PT) actual/Normal

14034

61983

1.69

307.65

4.6

3.7

94.6

91.9

30.72

13599

60515

(3011397) Hemoglobin [Presence] in Urine by Test strip

12405

58071

1.55

307.65

4.0

3.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

36991

194520

1.94

307.65

4.5

3.8

10.8

11.0

mm/h

1.96

34491

181448

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

10015

32831

2.27

307.65

2.3

1.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9193

40047

1.64

307.65

2.9

2.6

1.2

1.1

e6/l

0.26

5014

22502

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

22054

90486

2.08

307.65

2.1

1.8

97.6

pmol/l

0.03

11877

46748

(3020564) Creatinine [Moles/volume] in Serum or Plasma

47745

293820

2.13

307.65

18.7

13.2

73.1

75.2

umol/l

42.90

47736

293657

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

9661

39401

1.77

307.65

2.8

3.1

2.4

mmol/l

23.19

8296

34640

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

43730

259638

1.80

307.65

4.8

4.0

5.9

5.8

mmol/l

35.38

40582

240224

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

27742

125295

2.02

307.65

6.5

5.9

10.0

11.2

umol/l

60.64

26129

118963

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3718

11938

2.15

307.65

2.5

2.2

5629.0

6078.8

u/l

0.32

1217

5185

(3009508) Creatinine [Moles/volume] in Urine

15741

73793

1.60

307.65

3.5

3.1

7.8

mmol/l

0.04

13347

62863

(3006504) Eosinophils/100 leukocytes in Blood

25717

120480

1.83

307.65

7.1

5.8

2.8

2.9

17.78

24047

112912

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

43124

256660

1.72

307.65

14.7

10.8

89.6

84.2

ml/min/173m2

307.65

35812

210467

(3019309) Folate [Moles/volume] in Red Blood Cells

10675

34208

2.35

307.65

1.8

1.7

1147.9

1163.6

nmol/l

0.91

8356

25996

(3042517) Benzodiazepines panel - Urine

361

185.37

307.65

2.9

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2730

7253

2.58

307.65

2.0

1.7

—

(3018010) Neutrophils/100 leukocytes in Blood

26143

123837

1.82

307.65

7.0

5.6

56.6

56.7

0.91

24510

116691

(3013650) Neutrophils [#/volume] in Blood by Automated count

30963

148181

1.97

307.65

11.2

8.2

4.1

4.0

e9/l

9.53

27150

130001

(3007853) Bacteria identified in Skin by Aerobe culture

7104

28027

1.79

307.65

1.9

1.7

—

(3006315) Basophils [#/volume] in Blood

27650

128071

1.94

307.65

7.1

5.6

0.0

e9/l

0.03

24043

111869

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7134

20343

2.54

307.65

2.1

2.3

372.0

375.3

nmol/l

0.61

6491

18929

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1185

243.64

307.65

11.9

5.2

0.6

mmol/l

0.53

1095

(3014111) Lactate [Moles/volume] in Serum or Plasma

5117

18220

1.96

307.65

7.1

7.3

1.4

1.3

mmol/l

3.80

4898

17665

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4471

15688

1.97

307.65

1.7

1.6

—

(3011288) Drugs identified in Urine by Screen method

4686

4364

7.73

307.65

4.2

1.3

—

(3028300) Cannabinoids [Presence] in Urine

5464

9465

4.16

307.65

3.1

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

716

410

11.73

307.65

2.7

1.3

157.0

74.9

umol/l

5.91

353

191

(3002030) Lymphocytes/100 leukocytes in Blood

26432

125703

1.81

307.65

7.2

5.8

29.0

28.7

4.17

24724

117929

(3019198) Lymphocytes [#/volume] in Blood

28172

132362

1.91

307.65

7.1

5.6

2.0

1.9

e9/l

2.78

24979

117789

(3021387) Prolactin [Units/volume] in Serum or Plasma

3425

9707

2.43

307.65

1.7

1.6

352.1

274.4

mu/l

14.19

3042

8854

(3007164) IgA [Mass/volume] in Serum or Plasma

12486

51817

1.79

307.65

1.5

1.4

2.3

g/l

4.26

7211

33137

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

16627

67578

1.93

307.65

2.5

1.9

212.9

188.7

u/l

1.28

15709

63442

(3013826) Glucose [Moles/volume] in Serum or Plasma

29578

144031

1.85

307.65

5.6

4.2

6.5

6.6

mmol/l

7.02

27706

132813

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

616

516.02

307.65

2.3

1.4

149.3

110.9

nmol/l

—

532

(3024561) Albumin [Mass/volume] in Serum or Plasma

22771

100089

1.91

307.65

5.0

4.8

36.3

36.0

g/l

11.77

21113

93288

(3018418) pH of Serum or Plasma

16496

66313

1.96

307.65

4.2

4.1

7.4

4.66

3031

12815

(3023103) Potassium [Moles/volume] in Serum or Plasma

47134

275336

2.68

307.65

18.6

12.9

3.9

4.0

mmol/l

87.22

46134

267537

(3009466) Valproate [Moles/volume] in Serum or Plasma

2076

923

15.50

307.65

5.7

2.7

371.0

362.8

umol/l

0.81

1834

765

(3030467) Casts [#/volume] in Urine by Automated count

14853

65325

1.71

307.65

3.5

2.9

0.3

0.4

e6/l

2.13

11253

48120

(3015377) Calcium [Moles/volume] in Serum or Plasma

18957

76245

2.03

307.65

3.1

3.5

2.4

mmol/l

4.61

16661

67362

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

40691

205288

2.53

307.65

4.9

3.8

14.4

14.7

pmol/l

113.40

37742

188190

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8852

34174

1.87

307.65

2.0

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

38736

194474

2.31

307.65

8.5

7.1

76.6

76.5

u/l

0.09

36710

183458

(3035350) Ketones [Presence] in Urine by Test strip

24489

129454

1.49

307.65

4.1

3.2

0.0

estimate

1.13

4814

23844

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

46512

276092

2.27

307.65

17.4

11.4

20.3

22.6

mg/l

46.09

37858

212249

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

20649

80819

2.16

307.65

3.7

3.0

31.7

32.5

u/l

1.13

19576

77063

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2249

3252

4.75

307.65

1.4

1.2

—

(3002032) Base excess in Venous blood by calculation

5197

18952

1.91

307.65

4.7

3.9

2.0

1.8

mmol/l

2.18

4256

15627

(3019550) Sodium [Moles/volume] in Serum or Plasma

47070

274298

2.69

307.65

18.6

12.8

139.5

139.7

mmol/l

85.08

46146

267051

(4198724)

1102

198

37.68

307.65

2.5

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

18544

87875

1.63

307.65

4.0

3.0

47.3

54.2

ng/l

0.25

11232

53782

(3037522) Nuclear Ab [Titer] in Serum

8662

36098

1.71

307.65

1.4

1.3

476.8

575.9

titre

5.00

1596

7384

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

12837

55735

1.70

307.65

2.0

1.7

1.0

1.1

mg/l

1.75

9415

42318

(3012544) pH of Venous blood

5336

19773

1.88

307.65

4.7

3.9

7.4

0.80

102

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

24309

101921

2.11

307.65

6.5

5.7

1.2

mmol/l

0.17

22308

92461

(1001926) Buprenorphine [Presence] in Urine by Screen method

4806

6157

5.61

307.65

3.1

1.2

—

(3032080) INR in Blood by Coagulation assay

18825

93615

1.53

307.65

7.9

7.8

1.1

1.2

inr

18.14

5876

27727

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5026

16494

2.13

307.65

2.1

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

3943

1056

26.73

307.65

3.3

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

12505

57043

1.60

307.65

1.8

1.5

—

(3023368) Bacteria identified in Blood by Culture

13582

58636

1.73

307.65

4.9

4.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

14210

55926

1.95

307.65

2.4

2.2

2.8

2.9

mg/l

2.74

12201

48309

(3021589) Normoblasts [#/volume] in Blood

23367

116035

1.62

307.65

10.7

8.7

0.0

e9/l

0.72

19104

95843

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

44883

247535

2.63

307.65

6.0

4.3

1.8

2.1

mu/l

5.42

42216

229160

(3015736) pH of Urine

20529

97797

1.65

307.65

3.8

3.0

5.8

5.7

0.16

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9512

35595

1.95

307.65

3.9

3.5

0.8

mmol/l

2.90

8849

33410

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9986

44066

1.62

307.65

4.1

3.3

277.9

582.3

ng/l

8.18

6566

32215

(3044889) 12 lead EKG panel

32406

179440

1.54

307.65

3.8

3.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

14355

59910

1.82

307.65

1.4

1.3

1.4

1.8

u/ml

3.25

3672

17020

(3026782) Osmolality of Urine

10839

44719

1.77

307.65

3.0

2.6

522.5

553.6

mosm/kgh2o

29.14

9285

37977

(3021960) Folate [Moles/volume] in Serum or Plasma

12970

47552

2.08

307.65

1.6

1.5

20.1

20.6

nmol/l

3.49

11504

40701

(3026008) Bacteria identified in Urine by Culture

15397

69496

1.67

307.65

3.4

2.7

—

(40758558) Short blood count panel - Blood

14421

62322

1.74

307.65

8.0

6.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

35689

184269

1.94

307.65

4.1

2.6

47.4

42.9

u/l

16.77

33693

173965

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

23130

102034

1.92

307.65

2.6

2.2

3939.9

77.3

nmol/l

0.50

21210

93149

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

47921

295830

2.14

307.65

12.5

9.0

27.8

26.5

u/l

22.83

46672

286311

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

10638

48111

1.59

307.65

1.8

1.7

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

18588

85115

1.70

307.65

3.7

3.1

—

0.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

18411

74548

1.99

307.65

3.1

2.4

55.0

58.9

u/l

13.54

17010

69034

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4599

15928

2.00

307.65

3.0

3.6

4.5

4.6

pmol/l

4.47

3984

14484

(3019150) Specific gravity of Urine by Refractometry

12300

53292

1.70

307.65

4.3

3.6

1.0

kg/l

0.41

1590

8495

(3023183) Ammonium ion [Moles/volume] in Plasma

1609

3196

3.41

307.65

2.8

2.7

33.1

34.6

umol/l

1.59

1390

2725

(3023511) Choriogonadotropin [Units/volume] in Urine

2263

5226

2.96

307.65

1.5

1.3

—

(3001604) Monocytes [#/volume] in Blood

27534

127536

1.93

307.65

7.1

5.6

0.6

e9/l

1.13

23977

111443

(3031040) Bacteria [#/volume] in Urine by Automated count

33182

168620

1.86

307.65

5.4

3.8

1306.1

1198.2

e6/l

0.12

431

2120

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1256

272

31.35

307.65

1.9

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6349

21263

2.12

307.65

2.9

2.4

41.1

49.0

u/l

0.44

5442

18319

(3000850) Epithelial cells [#/volume] in Urine

11495

48727

1.73

307.65

2.9

2.4

6.6

5.6

e6/l

8.07

10087

42312

(3013115) Eosinophils [#/volume] in Blood

28383

132612

1.94

307.65

7.6

5.7

0.2

e9/l

5.49

25058

117559

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7476

27984

1.90

307.65

6.4

6.1

1.0

mmol/l

0.40

6988

26257

(3004789) Transferrin [Mass/volume] in Serum or Plasma

8031

33065

1.72

307.65

2.6

2.4

g/l

13.64

7363

30856

(3022096) Basophils/100 leukocytes in Blood

25030

116613

1.83

307.65

7.2

5.8

0.7

4.04

23399

109371

(3027944) Amphetamines [Presence] in Urine

5271

9439

4.01

307.65

2.9

1.2

—

(3018095) Leukocytes [#/volume] in Urine

18806

86029

1.71

307.65

4.2

3.4

76.8

85.4

e6/l

0.74

13220

58919

(3002582) Erythrocytes [#/volume] in Urine

15972

71685

1.69

307.65

3.6

3.0

53.1

86.4

e6/l

3.33

12336

53964

(3000764) Benzodiazepines [Presence] in Urine

5451

9315

4.22

307.65

3.0

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

26552

113670

2.14

307.65

7.1

6.4

1.2

mmol/l

1.86

22792

95882

(3009261) Glucose [Presence] in Urine by Test strip

24653

131467

1.47

307.65

4.2

3.3

0.0

estimate

0.09

4855

23817

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

11046

46337

1.74

307.65

1.7

1.6

32891942.4

42012023.5

pmol/l

0.80

9355

38994

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

11917

26526

3.58

307.65

2.2

1.4

1.5

1.3

211.01

10572

23904

(40768797) Stomach Pathology biopsy report

7996

33683

1.68

307.65

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10182

46352

1.57

304.34

1.3

31.8

35.2

iu/ml

0.36

2694

15178

(36660697) Celiac disease serology panel - Serum

5456

21064

1.80

303.75

1.2

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3762

12890

2.01

299.69

3.8

3.3

5.2

5.1

kpa

10.26

3509

11925

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

40801

244046

1.53

297.35

5.9

5.0

39.0

mmol/mol

0.32

38141

228385

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1982

5184

2.60

296.00

1.3

508.7

542.7

mg/l

0.63

1876

4972

(3009343) pH of Capillary blood

3713

12722

2.01

295.64

3.8

3.3

7.4

1.44

492

1690

(40761511) CBC panel - Blood by Automated count

47097

292138

1.85

295.59

15.9

10.6

—

(3042936) Bacteria identified in Isolate by Culture

7711

33075

1.64

293.34

2.2

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3607

12274

2.02

292.57

3.7

3.3

1.6

mmol/l

0.12

2685

8949

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3056

9802

2.13

289.42

4.9

4.5

24.2

mmol/l

0.34

2723

8913

(3000991) Gas panel - Venous blood

4754

17837

1.85

289.34

8.8

8.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

6552

27107

1.69

285.31

7.6

7.1

104.2

104.6

mmol/l

8.66

6394

26584

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3551

12166

2.00

282.32

1.6

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1777

4518

2.66

280.22

1.3

3.7

mmol/l

1.88

1650

4255

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1780

4534

2.66

279.70

1.5

3500.3

2202.6

e6/l

0.26

1420

3680

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1778

4530

2.66

279.25

1.4

35.4

33.4

e6/l

0.06

1339

3492

(3003396) Base excess in Arterial blood by calculation

5891

23834

1.72

277.65

7.7

7.3

1.2

0.9

mmol/l

3.99

4687

18774

(3027801) Oxygen [Partial pressure] in Arterial blood

5888

23827

1.72

277.27

7.7

7.3

12.3

13.0

kpa

21.59

5634

22747

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5889

23840

1.72

276.92

7.7

7.3

5.2

5.1

kpa

8.68

5639

22765

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7982

35000

1.61

276.21

2.3

2.1

29.6

29.7

1.52

7728

33998

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3407

11748

1.99

265.50

1.7

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1301

2898

3.03

259.85

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2252

6652

2.30

259.25

2.3

393.4

471.7

ug/l

0.63

2070

6215

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

34010

198514

1.40

253.73

3.7

3.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

9465

43922

1.53

253.20

1.3

7.7

11.8

u/ml

6.33

3437

18027

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1438

3452

2.81

252.10

1.6

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

719

1084

4.45

248.58

1.8

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3847

14178

1.86

245.71

1.4

1.3

24.6

28.0

iu/l

7.82

3192

12453

(3000494) Fungus identified in Specimen by Culture

6676

28775

1.62

244.96

1.6

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5257

21493

1.69

235.91

1.5

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2073

6151

2.29

235.80

1.4

291.4

276.2

ug/g

1.75

1127

3594

(3016502) Oxygen saturation in Arterial blood

5202

21285

1.69

232.55

8.1

7.8

95.5

96.1

6.87

5032

20445

(3044290) Cell count panel - Cerebral spinal fluid

1644

4413

2.52

232.34

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

15551

80671

1.40

228.37

2.6

2.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

4675

18699

1.72

226.62

2.7

10.3

10.6

g/l

7.23

4243

17216

(3009214) Lutropin [Units/volume] in Serum or Plasma

2505

8164

2.09

226.30

1.4

9.8

9.9

u/l

0.04

1979

6848

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4750

19162

1.71

223.10

1.2

126.8

151.8

iu/ml

3.70

1570

7612

(40760892) CBC W Ordered Manual Differential panel - Blood

12160

60714

1.43

220.12

5.2

4.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

4650

18899

1.69

211.94

8.7

7.8

8.2

9.5

mmol/l

31.46

4427

18101

(3019832) Treponema pallidum Ab [Presence] in Serum

7296

33203

1.53

208.87

1.8

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

232

15.92

207.38

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1476

4030

2.47

201.11

1.4

1.3

25.1

27.1

u/l

1.31

1186

3414

(3029937) Albumin [Presence] in Urine by Test strip

13268

68251

1.39

198.52

4.7

3.6

0.0

estimate

8.60

4833

23709

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4378

17833

1.69

197.16

2.4

2.3

23.9

23.1

au/ml

0.16

204

1263

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

553

822

4.50

194.39

1.9

1.3

2028672.4

1716579.7

iu/ml

0.16

(3013512) EKG study

13150

67734

1.39

194.36

4.0

3.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4769

19963

1.64

193.33

8.6

8.1

123.3

121.7

g/l

5.48

4613

19206

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3489

13407

1.78

192.89

7.3

25.0

24.8

mmol/l

2.30

3455

13304

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3712

14527

1.75

192.80

1.1

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2155

7078

2.06

190.10

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

2158

7105

2.06

189.13

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2851

10355

1.87

188.79

1.1

9.5

10.8

u/ml

0.06

158

(3019225) pH of Specimen

5120

21940

1.61

188.70

4.3

4.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4042

16306

1.70

188.21

1.3

45.6

49.2

au/ml

0.30

105

728

(3019060) Gas panel - Arterial blood

3422

13172

1.77

187.92

5.3

4.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2130

7012

2.06

186.69

1.2

1.1

—

(3022313) Gas panel - Capillary blood

2598

9224

1.91

184.14

4.0

3.4

—

(3025941) Bacteria identified in Stool by Culture

3794

15257

1.70

178.30

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2462

8685

1.92

177.71

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2554

9123

1.90

177.62

1.8

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

11871

60961

1.38

175.21

2.5

2.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

3605

14494

1.70

169.18

1.9

1.3

g/l

0.11

3291

13319

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11829

61079

1.37

167.38

3.1

2.9

1014.5

1211.3

ng/l

4.02

9705

51933

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2308

8133

1.92

166.90

4.1

3.5

24.8

mmol/l

0.06

2182

7535

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2714

10138

1.82

163.88

1.3

1.2

0.6

1.0

u/ml

1.47

219

861

(3007461) Platelets [#/volume] in Blood

49270

315701

1.90

162.30

26.3

16.5

260.8

253.8

e9/l

105.84

48345

307729

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

183

+∞

161.61

7.0

0.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

5310

23751

1.54

161.00

2.8

2.6

1.8

1.7

1.36

4674

21349

(3003181) Sodium [Moles/volume] in Urine

1130

3033

2.50

159.29

1.5

1.4

59.5

65.4

mmol/l

4.05

880

2448

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2554

9443

1.83

159.26

3.8

2.8

1.6

1.2

32.34

2538

9391

(3005322) IgE [Units/volume] in Serum or Plasma

4147

17567

1.61

158.67

1.4

1.3

253.6

231.0

u/ml

0.33

3811

16331

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

22089

125432

1.29

158.60

4.2

3.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4323

18508

1.60

158.33

4.1

3.7

1.2

mmol/l

2.42

3784

16238

(3052851) Hemolysis interference index of Serum or Plasma

1971

6701

1.99

157.81

3.1

3.0

—

(3035941) MCH [Entitic mass]

49276

316036

1.88

155.58

26.1

16.4

30.2

1.62

48785

312093

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

12746

67208

1.34

155.28

1.7

1.6

1.5

1.3

mmol/l

65.75

11028

56847

(3024731) MCV [Entitic volume]

49278

316079

1.88

154.97

26.2

16.4

90.5

0.06

48785

312121

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6096

28288

1.49

154.89

7.5

5.9

—

(3026361) Erythrocytes [#/volume] in Blood

49280

316117

1.87

154.47

26.3

16.5

4.5

e12/l

35.02

48259

307388

(3010813) Leukocytes [#/volume] in Blood

49287

316197

1.87

153.98

26.3

16.5

6.9

6.6

e9/l

92.56

48264

307429

(3000963) Hemoglobin [Mass/volume] in Blood

49283

316262

1.87

151.67

26.4

16.6

135.5

136.6

g/l

56.01

48790

312363

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

18313

101910

1.30

150.80

4.4

3.3

—

(3023410) Appearance of Cerebral spinal fluid

857

2054

2.80

150.34

1.6

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

159

18.23

150.20

1.5

1.0

2.5

—

mmol/l

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3919

16609

1.61

149.23

3.8

3.9

85.9

88.7

ng/l

0.95

3390

14538

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2476

9289

1.81

147.04

3.8

2.8

0.7

0.05

2375

8918

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1390

4269

2.19

144.91

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1390

4271

2.19

144.75

1.4

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

4052

17456

1.58

143.91

1.2

—

(21494755) Public health laboratory ask at order entry panel

3761

37549

0.64

142.61

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3159

12845

1.67

141.23

8.1

6.6

24.8

24.5

mmol/l

2.62

2987

11888

(3004119) Hemoglobin [Mass/volume] in Venous blood

3105

12570

1.68

141.13

4.1

3.3

131.2

129.7

g/l

3.35

3031

12297

(4010399)

4033

17467

1.58

139.83

1.5

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2807

11090

1.72

139.46

9.3

9.8

24.4

24.3

mmol/l

0.69

2593

10471

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3236

13286

1.66

139.37

9.5

9.2

1.5

1.3

20.41

3222

13200

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3234

13277

1.66

139.31

9.6

9.4

0.7

0.05

3221

13208

(3008295) Osmolality of Serum or Plasma

751

1748

2.88

138.83

1.6

1.4

281.6

280.0

mosm/kgh2o

0.96

561

1403

(3017181) Myelocytes/100 leukocytes in Blood

4658

20916

1.52

137.37

4.5

4.1

1.0

0.03

1285

5542

(3007566) Smooth muscle Ab [Titer] in Serum

1930

6833

1.91

137.17

1.3

84.4

130.7

titre

2.94

156

646

(3014007) Fractional oxyhemoglobin in Arterial blood

3241

13399

1.64

135.76

9.6

9.3

93.6

94.3

6.92

3229

13354

(1616796) Gas panel - Central venous blood

1435

4595

2.10

134.70

4.0

3.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2425

9343

1.76

131.40

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1528

5062

2.03

131.09

3.3

3.0

24.7

24.5

mmol/l

0.91

1370

4433

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1646

5605

1.98

130.89

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1466

4788

2.06

130.65

3.5

3.0

8.7

8.5

kpa

5.16

1375

4447

(40761535) Cells panel - Urine sediment

4171

18474

1.54

130.62

3.9

3.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3456

14657

1.60

130.50

1.3

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4283

19274

1.52

124.36

2.6

2.1

12.2

12.7

nmol/l

3.87

3740

17556

(3018405) Lactate [Moles/volume] in Arterial blood

1892

6879

1.85

123.81

4.6

3.8

1.4

1.3

mmol/l

0.92

1871

6754

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4003

17778

1.53

123.50

2.6

2.1

6.9

7.6

ug/l

0.68

3387

15812

(3021440) Promyelocytes/100 leukocytes in Blood

4411

20003

1.51

123.46

4.6

4.1

0.1

0.02

1167

5184

(3022217) INR in Platelet poor plasma by Coagulation assay

5791

27728

1.43

122.83

18.7

22.4

1.2

1.3

inr

4.47

806

4245

(3020891) Body temperature

2116

7990

1.79

122.56

5.9

4.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

4230

19082

1.51

121.26

4.2

3.9

0.7

0.13

920

4068

(3010421) pH of Blood

1603

5571

1.94

120.14

4.5

3.4

7.4

11.65

1367

4705

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2055

7745

1.79

119.73

1.9

1.7

0.2

g/l

0.25

1942

7367

(3034770) Mitochondria Ab [Titer] in Serum

1859

6799

1.84

119.36

1.2

1.3

895.0

1047.0

titre

0.33

212

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1271

4068

2.10

119.35

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1279

4107

2.09

119.09

1.2

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2099

7988

1.77

118.37

1.9

1.7

1.2

g/l

1.60

1990

7627

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1672

5934

1.90

117.75

1.2

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3120

13334

1.59

113.54

1.1

156.7

193.0

titre

0.31

388

(3025159) Blasts/100 leukocytes in Blood

4155

18991

1.49

111.36

4.6

4.1

0.1

0.3

3.75

988

4414

(3027315) Oxygen [Partial pressure] in Blood

1410

4838

1.96

109.57

4.7

3.5

8.9

8.8

kpa

1.58

1376

4737

(3012501) Base excess in Blood by calculation

1401

4801

1.96

109.26

4.7

3.5

2.5

2.4

mmol/l

0.32

947

3198

(3013290) Carbon dioxide [Partial pressure] in Blood

1401

4803

1.96

109.13

4.7

3.5

5.1

5.0

kpa

6.91

1367

4702

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

732

1915

2.56

108.66

2.0

2.2

20.5

19.0

nmol/l

3.37

679

1849

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

998

3012

2.22

108.39

2.1

1.8

5468.8

3268.1

titre

0.57

121

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

739

1969

2.51

105.71

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2415

9884

1.65

104.45

1.6

1.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

1626

5960

1.83

103.51

5.0

4.1

3.8

3.9

mmol/l

4.72

1527

5637

(3035637) Corticotropin [Mass/volume] in Plasma

950

2867

2.22

103.19

1.5

1.6

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

141

10.65

103.11

1.1

1.2

54.3

37.6

mg/l

2.89

(3022145) Colonoscopy Study observation

5911

29221

1.39

103.01

1.3

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

732

1967

2.49

102.90

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

831

2371

2.35

102.72

1.5

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2239

9050

1.67

101.53

4.5

3.7

51.2

47.8

7.72

2214

8959

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1284

4421

1.95

98.73

1.5

1.4

0.4

nmol/l

1.07

1009

3477

(3023520) Reticulocytes [#/volume] in Blood

3818

17560

1.48

98.65

2.7

72.5

69.7

e9/l

4.14

2812

13219

(3020630) Protein [Mass/volume] in Serum or Plasma

3831

17633

1.48

98.61

2.4

2.7

66.6

66.8

g/l

0.53

3480

16230

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1528

5582

1.84

98.27

1.3

—

(3024928) Oxygen saturation in Venous blood

1266

4348

1.95

98.05

3.9

3.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2375

9856

1.63

97.12

4.2

3.2

25.4

25.3

mmol/l

1.45

2309

9567

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2036

8127

1.69

96.68

1.9

1.7

38.7

40.5

nmol/l

2.28

1981

7977

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1447

5240

1.85

95.64

1.3

268.5

254.8

u/ml

1.01

957

3339

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1498

5494

1.83

95.12

2.1

1.8

192.2

199.9

pmol/l

1.78

1416

5279

(3017509) Phencyclidine [Presence] in Urine

187

195

6.38

94.39

2.3

1.1

—

(3036489) Thrombin time

2321

9651

1.62

94.10

2.3

2.1

21.3

21.4

0.20

1995

8315

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

765

2201

2.32

92.83

1.1

—

(3008898) HLA-B27 [Presence]

2376

9973

1.61

92.70

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

41920

264292

1.28

92.49

18.7

12.0

40.0

40.3

8.87

31146

205304

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5317

26284

1.38

91.89

4.0

4.5

232.2

243.7

u/l

7.07

4986

25075

(3021901) Oxygen saturation in Capillary blood

1102

3701

2.00

90.90

2.9

2.8

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

396

810

3.26

90.78

1.4

1.5

557.5

776.2

mu/l

0.76

372

778

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1046

3455

2.03

90.31

1.3

1.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

401

831

3.22

90.08

1.4

1.5

73.2

72.8

0.26

377

799

(3029634) Reagin Ab [Titer] in Serum by VDRL

1122

3810

1.97

89.73

2.5

2.1

10.6

5.6

titre

0.80

103

(1761868) Lipid panel - Serum or Plasma

14477

111093

0.81

89.35

2.7

2.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4808

23600

1.39

86.38

3.9

2.9

—

(40767503) Oxygen content in Capillary blood by calculation

1265

4540

1.87

85.92

2.9

2.3

17.0

16.6

1.96

685

2317

(3016244) Insulin [Units/volume] in Serum or Plasma

600

1602

2.50

85.53

3.2

29.8

25.5

mu/l

1.69

563

1515

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

693

1986

2.33

84.87

1.2

35.4

46.1

mg/l

5.78

574

1654

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

43723

277800

1.30

84.40

4.9

4.4

2.8

mmol/l

0.95

40634

259719

(3028271) Lactate [Moles/volume] in Capillary blood

992

3307

2.01

83.51

2.3

1.7

1.8

1.7

mmol/l

2.50

973

3226

(3026389) Candida sp identified in Specimen by Organism specific culture

1057

3609

1.96

83.22

1.4

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1814

7317

1.67

82.66

1.3

26.6

37.6

u/ml

0.95

467

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

541

1396

2.59

82.63

1.4

1.3

5.2

umol/l

0.13

496

1307

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1963

8083

1.63

82.58

1.9

1.8

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

617

1708

2.41

81.54

1.2

2.0

2.1

mmol/l

0.58

567

1596

(1002224) Polysomnography panel

2684

11925

1.52

81.44

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1435

5451

1.77

81.10

1.3

1.2

36.4

43.7

u/ml

0.94

134

558

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

667

1919

2.32

80.99

1.1

236.9

275.0

mg/l

3.45

575

1691

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6886

57019

0.77

80.61

3.7

3.9

21.6

21.9

0.61

2620

25504

(3037121) Protein [Mass/volume] in Urine

1935

7988

1.63

80.55

3.3

3.2

0.3

g/l

1.26

862

3570

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

9227

50183

1.27

79.71

1.5

—

(4027681)

561

1502

2.49

79.55

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

365

775

3.14

78.95

1.0

35.3

34.7

ng/l

0.10

276

539

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

363

769

3.14

78.81

1.0

257.4

329.9

ng/l

0.85

277

543

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

364

773

3.14

78.72

1.0

839.3

822.7

ng/l

0.24

270

520

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

499

1273

2.61

77.97

1.1

2.3

6.2

nmol/l

1.30

265

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2294

9941

1.55

77.88

1.3

222.5

224.6

miu/ml

0.09

946

5005

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

624

1775

2.35

77.73

1.1

294.0

290.8

mg/l

0.44

555

1606

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1371

5203

1.77

77.72

1.4

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

410

942

2.90

77.71

2.0

1.8

2.0

umol/l

0.07

385

885

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3589

32466

0.71

76.64

1.6

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

13033

73954

1.23

76.25

3.7

2.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4901

42212

0.75

76.08

2.7

2.8

0.6

0.8

ug/l

24.44

3153

25366

(40768804) Tissue Pathology biopsy report

18812

110675

1.20

75.73

2.1

2.0

—

(3016038) Potassium [Moles/volume] in Urine

464

1158

2.67

75.65

1.3

1.2

32.9

34.6

mmol/l

0.71

403

1005

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1901

7959

1.61

74.69

2.2

1.9

2.0

2.4

ug/l

0.59

1680

7097

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

643

1888

2.27

74.56

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1425

5544

1.72

74.08

1.5

1.4

18.1

21.5

u/ml

0.47

112

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

43092

274135

1.26

73.91

4.5

4.0

4.7

mmol/l

21.68

40284

257891

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2650

11983

1.49

73.75

10.3

9.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2422

10754

1.52

73.55

1.7

1.6

3.9

3.3

mg/l

1.84

1884

7066

(3020717) Zinc [Moles/volume] in Serum or Plasma

461

1170

2.63

72.80

1.7

1.4

21.1

28.2

umol/l

5.35

437

1115

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1367

5299

1.73

71.98

1.7

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1425

5597

1.71

71.59

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2165

9438

1.54

71.48

2.2

1.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2362

10519

1.51

70.67

1.5

9.8

13.9

u/ml

1.24

320

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

361

815

2.95

70.58

2.7

2.3

52.8

51.3

umol/l

0.40

304

685

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1811

7608

1.60

70.12

2.8

2.5

180.6

183.4

0.64

1702

7228

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

786

2587

2.03

68.56

1.4

1.3

23.3

25.1

nmol/l

0.14

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1323

5161

1.72

68.11

1.5

110.9

111.3

u/ml

0.04

268

1191

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1319

5145

1.72

67.92

1.8

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1113

4142

1.80

67.34

1.6

0.7

0.8

g/l

2.48

860

3115

(3004588) Protein electrophoresis panel - Serum or Plasma

3031

14313

1.43

67.25

2.2

2.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2417

10938

1.49

66.87

2.0

2.1

39.8

39.6

u/l

0.23

2188

9837

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

42761

272400

1.25

66.81

4.4

4.0

1.4

1.5

mmol/l

189.27

39812

255356

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

950

3384

1.88

66.04

1.3

0.2

0.3

nmol/l

1.28

189

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

953

3403

1.87

65.75

1.3

1.9

1.3

nmol/l

0.21

915

3286

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1927

8347

1.55

65.38

2.6

2.3

94.5

92.8

2.41

1792

7765

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1964

8557

1.54

64.92

2.1

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

11858

67520

1.21

64.90

2.6

2.5

2240.3

4128.9

umol/l

9.88

10254

59775

(3022806) Fractional oxyhemoglobin in Capillary blood

799

2699

1.98

64.89

2.2

1.6

90.3

90.4

0.06

785

2659

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1320

5226

1.69

64.39

6.7

5.7

1177.5

1192.8

iu/ml

0.01

173

789

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

367

882

2.77

64.29

2.1

1.8

28.2

29.4

umol/l

1.15

355

849

(3017732) Neutrophils [#/volume] in Blood

3724

18385

1.37

63.59

3.2

2.4

4.2

4.1

e9/l

1.37

2868

14770

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

569

1703

2.23

63.16

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

566

1692

2.23

63.01

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1905

8306

1.54

62.74

1.7

1.6

234.2

310.9

titre

0.57

336

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

41340

262853

1.22

61.95

4.0

3.6

1.4

1.3

mmol/l

156.61

38208

245444

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

291

629

3.08

61.28

2.9

2.8

29.2

27.8

umol/l

0.76

214

494

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1799

7785

1.55

61.27

3.2

2.6

3.5

3.6

g/l

1.59

1707

7437

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

27.02

61.13

1.7

1.0

295.5

170.7

nmol/l

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

102.24

60.83

1.4

1.0

433.3

774.2

nmol/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9093

71033

0.82

60.80

4.1

4.5

2.6

2.7

ug/l

0.04

8113

64970

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1613

6820

1.59

60.73

1.3

8.7

8.9

u/ml

0.03

229

1107

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

334

791

2.81

60.13

1.5

1.4

13.9

15.2

pmol/l

3.34

266

683

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

792

2743

1.93

59.91

7.2

6.1

11.0

11.3

mg/l

0.90

721

2536

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1629

6928

1.58

59.82

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

858

3064

1.87

59.21

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

481

1383

2.32

58.62

1.1

1.0

1.1

u/l

0.60

216

639

(3012516) Albumin [Mass/volume] in Urine

12072

69396

1.20

58.62

3.4

3.3

500.2

419.9

mg/l

0.88

7685

43431

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1279

5161

1.66

58.08

2.3

2.1

133.4

131.1

g/l

2.37

952

3730

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1724

7484

1.55

57.87

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

285

635

2.99

57.10

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1577

6732

1.57

56.98

1.3

7.5

6.3

u/ml

0.20

147

735

(3006922) Hepatitis E virus Ab [Presence] in Serum

562

1747

2.14

56.94

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

414

1127

2.45

56.86

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1551

6606

1.57

56.58

1.8

1.9

16.0

21.1

iu/l

0.17

532

2556

(3047181) Lactate [Moles/volume] in Blood

1616

6961

1.56

56.13

6.3

5.4

1.3

mmol/l

2.13

1426

6146

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

424

1177

2.40

55.87

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1570

6732

1.56

55.63

2.0

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2574

12224

1.42

55.07

2.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

464

1352

2.29

54.90

1.5

5.6

5.7

u/l

0.07

395

1142

(3020682) Albumin/Creatinine [Ratio] in Urine

12584

72977

1.19

54.66

4.1

4.0

9.7

8.5

mg/mmol

1.69

7927

46056

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1017

3933

1.73

54.01

3.3

2.8

503.0

7934.1

u/ml

1.35

217

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

27.65

53.93

1.8

1.3

340.8

213.7

nmol/l

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

31.85

53.62

1.7

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2111

9711

1.46

53.59

1.8

1.5

g/l

0.02

1821

8353

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

985

3784

1.74

53.55

1.8

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

818

2972

1.84

53.53

1.3

—

nmol/l

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3568

17961

1.34

53.36

3.0

2.7

144.3

184.7

ng/l

7.17

3186

16284

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1831

8228

1.49

52.27

1.4

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

685

2368

1.93

52.15

1.7

1.8

—

(3001186) Copper [Moles/volume] in Serum or Plasma

248

541

3.05

51.54

1.4

1.3

17.1

16.8

umol/l

0.43

217

479

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

555

1790

2.07

51.22

2.8

2.5

810.3

712.9

e6/l

0.71

206

752

(3025468) Yersinia sp identified in Specimen by Organism specific culture

808

2971

1.82

50.91

1.5

1.4

—

(40761536) Microorganisms panel - Urine sediment

4311

22430

1.30

50.89

4.7

3.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

511

1603

2.12

50.67

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

808

2976

1.81

50.64

1.5

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

236

506

3.10

50.47

1.4

1.2

132.0

127.5

nmol/l

0.13

168

389

(3005988) Vibrio sp identified in Specimen by Organism specific culture

808

2980

1.81

50.42

1.5

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1304

5487

1.59

50.08

1.3

1.2

2.4

5.8

u/ml

1.75

441

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

812

3008

1.80

49.95

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

827

3082

1.79

49.87

1.5

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

511

1614

2.11

49.80

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

406

1165

2.32

49.80

1.3

1.2

256.7

343.3

u/l

0.90

379

1086

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5584

30089

1.26

49.69

4.3

4.2

30.7

32.4

24.17

4031

21128

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1536

6722

1.53

49.67

1.3

1.5

9.2

13.4

iu/ml

1.04

174

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

881

3351

1.76

49.60

1.1

1.5

g/l

0.34

792

3055

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1285

5404

1.59

49.47

1.2

22.9

15.0

u/ml

0.25

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2443

22004

0.72

49.46

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1784

8070

1.48

49.28

1.1

5.2

5.5

u/ml

0.09

187

1196

(4062490)

726

2615

1.85

48.86

1.5

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

674

2370

1.90

48.82

7.1

5.0

7.2

mmol/l

0.01

550

1941

(3027135) IgG subclass 1 [Mass/volume] in Serum

725

2618

1.85

48.41

1.5

1.4

6.5

6.8

g/l

1.53

532

1797

(3024139) IgG subclass 3 [Mass/volume] in Serum

724

2614

1.85

48.37

1.5

1.4

0.4

g/l

2.70

535

1798

(21494815) CD4 cells/100 lymphocytes in Specimen

640

2219

1.92

48.34

2.5

2.1

43.4

40.2

0.99

283

(3019230) Fractional oxyhemoglobin in Venous blood

958

3759

1.70

48.33

4.3

3.2

64.3

65.8

1.23

952

3745

(3028192) IgG subclass 2 [Mass/volume] in Serum

724

2615

1.85

48.31

1.5

1.4

2.9

3.0

g/l

1.18

528

1796

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1932

8913

1.45

48.28

5.6

4.7

1.9

1.6

12.86

1815

8331

(3024522) Salmonella sp identified in Specimen by Organism specific culture

807

3016

1.79

48.23

1.5

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2097

9831

1.43

48.09

1.4

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1409

6115

1.54

47.32

2.2

2.3

0.0

g/l

1.11

1285

5650

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1549

6866

1.51

47.20

2.3

2.4

0.6

0.8

g/l

1.44

1352

5983

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1036

4182

1.66

47.01

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1697

7672

1.48

47.00

2.2

2.3

3.0

3.1

g/l

4.34

1334

6019

(3034274) Bile acid [Moles/volume] in Serum --fasting

1029

4151

1.66

46.82

2.0

2.2

5.8

6.4

umol/l

0.63

763

3045

(3007930) Methemoglobin/Hemoglobin.total in Blood

1895

8767

1.45

46.64

5.7

4.8

0.9

0.46

1783

8196

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

984

3929

1.67

46.55

1.6

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1428

6256

1.53

45.95

2.1

2.2

38.9

37.9

g/l

6.96

1245

5442

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

5920

32378

1.24

45.88

1.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1773

8144

1.46

45.30

2.1

2.3

7.1

7.4

g/l

5.96

1366

6152

(3003338) MCHC [Mass/volume]

38719

246482

1.17

45.20

22.7

14.0

332.9

g/l

0.96

38468

244733

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1769

8134

1.46

44.95

2.1

2.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

470

1499

2.09

44.74

2.3

2.0

100.4

97.2

1.06

438

1390

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1765

8125

1.46

44.58

2.1

2.3

3.7

3.8

g/l

1.01

1312

5831

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1304

5640

1.55

44.47

2.2

2.3

0.0

g/l

0.44

1185

5188

(3011412) CD3 cells [#/volume] in Blood

680

2477

1.83

44.22

2.6

2.3

1.3

1.1

e9/l

4.54

412

1479

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1025

4202

1.63

43.81

1.3

1.2

3.9

3.8

u/ml

0.15

473

1912

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

727

2717

1.78

43.49

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1285

5576

1.54

43.19

2.2

2.3

0.0

g/l

0.00

1184

5175

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1658

7588

1.46

43.16

2.1

2.3

9.9

10.3

g/l

2.66

1401

6407

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

331

925

2.38

43.13

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

776

2964

1.75

43.12

1.7

1.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

380

1134

2.23

42.67

1.3

58.6

67.8

0.77

145

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

220

505

2.90

42.05

1.9

2.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

607

2175

1.86

41.60

1.7

1.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

516

1768

1.94

40.44

1.4

11.2

11.9

umol/l

1.67

480

1714

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1045

4392

1.59

40.37

1.3

1.2

3.6

3.7

u/ml

0.13

353

1538

(3025130) Human papilloma virus identified in Specimen

989

4111

1.61

40.00

1.7

—

(3051651) Icteric interference index of Serum or Plasma

414

1314

2.10

39.97

4.1

3.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

273

724

2.51

39.78

2.5

2.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

438

1428

2.04

39.42

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

905

3695

1.63

39.35

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

496

1694

1.95

39.25

1.2

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

304

854

2.37

39.22

1.3

1.2

110.9

111.2

0.05

275

766

(3039443) Prostate specific Ag panel - Serum or Plasma

449

5602

0.53

39.02

1.5

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

370

1135

2.17

38.94

1.6

1.5

—

(3045716) Anion gap in Serum or Plasma

308

880

2.33

38.29

2.6

9.1

mmol/l

0.06

225

617

(40757494) Bilirubin.total [Moles/volume] in Blood

349

1056

2.20

37.99

2.2

2.1

16.3

30.6

umol/l

1.39

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

712

2753

1.72

37.96

2.1

1.9

22.6

26.2

mg/l

0.89

188

714

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

822

3311

1.66

37.69

1.5

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1106

4789

1.54

37.57

3.0

2.0

0.9

0.8

nmol/l

3.85

918

4069

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2468

12380

1.34

37.46

3.0

2.5

0.3

e6/l

0.08

2386

11999

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1524

7055

1.45

37.37

2.1

10.7

mg/l

0.08

1415

6623

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

562

2035

1.84

37.33

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

562

2037

1.84

37.22

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

264

712

2.47

37.20

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

950

3981

1.59

37.19

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

557

2014

1.84

37.17

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

562

2040

1.84

37.04

1.2

—

(44790049)

669

2560

1.74

37.01

1.7

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

969

4085

1.58

36.99

1.1

120.0

118.3

0.76

874

3701

(44806118)

669

2561

1.74

36.96

1.7

1.5

—

(44790047)

669

2561

1.74

36.96

1.7

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

725

2839

1.70

36.95

1.5

1.4

—

(44790048)

669

2562

1.74

36.91

1.7

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

557

2019

1.84

36.88

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

557

2020

1.84

36.83

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

318

938

2.26

36.79

1.3

1.2

0.3

g/l

0.87

256

746

(3001556) Androgen free Index in Serum or Plasma

138

259

3.54

36.31

1.3

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

427

1425

1.99

36.12

1.4

1.6

6.2

8.5

ug/l

3.25

392

1286

(3026250) Tacrolimus [Mass/volume] in Blood

366

1153

2.11

36.08

39.4

35.2

7.4

ug/l

0.04

337

1049

(3039162) Centromere protein B Ab [Units/volume] in Serum

818

3334

1.64

35.85

1.3

59.2

52.2

u/ml

0.25

228

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1540

7206

1.43

35.64

2.7

2.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

729

2895

1.68

35.31

1.6

35.6

35.8

iu/ml

0.01

132

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

511

1831

1.86

35.11

2.2

2.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

252

684

2.45

35.07

1.2

15.4

19.8

0.34

130

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

270

759

2.37

34.86

1.2

—

(4306422)

988

4246

1.55

34.73

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

498

1776

1.87

34.73

2.8

2.5

532.0

527.7

e6/l

0.05

425

1477

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

222

569

2.59

34.72

1.2

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3790

20312

1.26

34.66

2.9

2.5

72.5

67.8

ml/min/173m2

8.44

1498

7700

(3011985) Renin [Units/volume] in Plasma

819

3368

1.62

34.66

1.6

73.0

61.2

mu/l

0.70

721

3045

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

541

1985

1.82

34.50

2.8

2.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

165

362

3.03

34.17

1.2

—

(3000492) Spirometry study

5005

27687

1.22

34.10

1.5

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

557

2071

1.79

34.02

1.2

1.1

77.4

67.1

u/ml

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

212

538

2.62

33.82

3.1

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

212

538

2.62

33.82

3.1

2.3

—

(3045414) Leukocytes [Presence] in Urine

2299

11599

1.33

33.51

1.9

1.8

—

(1175426) CD3 cells/100 lymphocytes in Blood

538

1989

1.80

33.49

2.2

2.0

74.3

72.6

1.89

521

1918

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

536

1982

1.80

33.35

1.4

1.3

1.5

1.4

nmol/l

1.95

493

1783

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

482

1726

1.86

33.22

2.8

2.5

0.2

e9/l

0.69

422

1481

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

347

1109

2.08

33.02

1.5

1.6

17.6

5.7

nmol/l

0.34

278

925

(3010015) Selenium [Moles/volume] in Serum or Plasma

103

167

4.09

33.00

2.3

1.9

1.3

umol/l

0.59

149

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

484

1740

1.85

32.95

1.2

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

512

1874

1.82

32.93

1.7

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

512

1874

1.82

32.93

1.7

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

512

1874

1.82

32.93

1.7

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

944

4066

1.55

32.88

1.1

876.7

564.2

iu/ml

0.14

220

956

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

285

843

2.25

32.83

2.1

2.5

1.0

1.1

ug/l

0.45

270

797

(3019977) pH of Arterial blood

333

1052

2.11

32.66

2.8

2.3

7.4

1.40

392

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

+∞

32.66

3.1

0.0

2.7

—

ug/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1443

6795

1.42

32.27

5.3

3.4

1.5

1.4

mg/l

1.37

1338

6298

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

527

1965

1.79

31.92

2.2

2.0

12.2

14.5

3.74

264

903

(44813793)

529

1979

1.78

31.70

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

971

4248

1.53

31.54

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

14.92

31.34

1.3

1.0

—

mmol/l

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

371

1252

1.97

30.52

1.1

7.0

11.0

u/ml

1.33

214

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

100

169

3.93

30.43

3.6

3.4

2.3

mg/l

0.06

145

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1347

6346

1.42

30.05

1.1

1.6

1.8

u/ml

0.17

610

2532

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

620

2466

1.67

29.94

1.8

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1014

4529

1.49

29.88

3.6

3.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

741

3088

1.60

29.78

1.6

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

208

558

2.48

29.76

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

146

324

2.99

29.74

2.1

2.0

1.2

mmol/l

0.20

141

307

(3011048) Pyruvate [Moles/volume] in Blood

104

4.85

29.71

1.3

1.5

84.8

71.4

umol/l

1.64

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

744

3107

1.60

29.65

1.3

1.4

343.2

288.7

pmol/l

2.57

588

2432

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

371

1273

1.94

29.13

2.3

1.9

141.4

137.3

0.40

348

1205

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

237

685

2.30

28.87

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

275

848

2.16

28.74

2.1

1.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

203

548

2.46

28.69

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1033

4676

1.47

28.51

1.3

1.2

54.8

145.5

titre

2.24

102

(3003888) Timothy IgE Ab [Units/volume] in Serum

1220

5703

1.43

28.44

1.1

5.4

5.8

u/ml

0.41

691

2940

(3008116) Ketones [Moles/volume] in Urine by Test strip

157

373

2.80

28.43

1.6

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

605

2426

1.66

28.36

3.7

3.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

939

4183

1.50

28.05

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

150

352

2.83

27.78

2.5

2.1

1.2

mmol/l

0.83

145

334

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

536

2096

1.70

27.60

1.2

92.0

205.7

titre

1.60

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

537

2101

1.70

27.60

1.2

159.6

198.4

titre

0.54

367

(40768443) Skin Pathology biopsy report

2189

11277

1.30

27.42

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

778

3346

1.55

27.36

2.5

—

(3014271) Vancomycin [Susceptibility]

256

783

2.17

27.33

3.2

2.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

734

3126

1.56

26.96

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

200

555

2.39

26.71

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

192

523

2.44

26.67

1.1

6.2

7.1

mg/g

1.27

178

500

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

625

2573

1.62

26.47

1.2

65.9

64.3

u/l

0.14

433

1736

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

391

1413

1.84

26.32

2.9

2.7

40.3

39.3

0.33

121

500

(3017569) Oxygen content in Arterial blood

266

845

2.09

25.85

2.0

2.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

197

554

2.36

25.58

1.1

—

(3039000) Anion gap in Blood

1051

4876

1.44

25.57

7.8

6.5

11.2

11.1

mmol/l

0.11

954

4371

(3018572) Chloride [Moles/volume] in Blood

1051

4877

1.44

25.54

7.8

6.5

105.0

105.3

mmol/l

1.01

954

4373

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

411

1524

1.79

25.49

1.8

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

196

551

2.36

25.47

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

870

3895

1.49

25.41

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

462

1775

1.73

25.39

1.2

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

46.48

25.37

1.4

1.2

154.8

177.5

nmol/l

—

(3030313) Adrenal Ab [Titer] in Serum

113

237

3.17

25.32

1.1

—

(3010503) CD19 cells [#/volume] in Blood

412

1535

1.79

25.16

2.8

2.5

0.3

e9/l

0.38

400

1501

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

991

4562

1.45

25.14

1.1

16.0

11.5

au/ml

0.50

344

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

435

1648

1.76

25.11

2.8

3.4

114.8

130.3

nmol/l

0.46

427

1628

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

702

3010

1.55

25.07

1.2

1.1

95.2

96.2

0.42

654

2832

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

185

513

2.40

24.79

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1701

8588

1.32

24.67

1.7

1.6

3.6

4.0

iu/ml

0.05

357

1734

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1145

5431

1.41

24.65

1.1

1.3

1.1

u/ml

0.43

522

2296

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

163

427

2.54

24.59

1.5

1.7

—

(4268621)

679

2906

1.56

24.46

2.5

2.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

196

563

2.31

24.31

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

727

3164

1.53

24.30

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

298

1011

1.96

24.28

1.5

1.4

—

(40768800) Prostate Pathology biopsy report

370

4254

0.57

24.28

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

490

1943

1.68

24.05

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

297

1011

1.95

23.98

1.5

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

270

891

2.01

23.78

1.1

93.4

90.7

0.69

124

441

(3011897) Casein IgE Ab [Units/volume] in Serum

163

436

2.48

23.59

1.1

1.2

9.5

7.3

u/ml

0.11

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

761

3367

1.51

23.57

2.5

2.9

1363.0

546.1

u/ml

0.29

716

3194

(3028679) Herpes simplex virus Ab [Presence] in Serum

399

1505

1.76

23.42

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1127

5380

1.40

23.40

1.1

2.3

u/ml

0.03

304

1313

(3027923) C peptide [Moles/volume] in Serum or Plasma

338

1217

1.85

23.10

1.6

1.2

nmol/l

0.02

248

981

(3006245) CD3-CD19+ cells/100 cells in Blood

290

995

1.94

22.92

2.4

2.1

10.7

10.1

0.29

275

921

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

359

1323

1.80

22.79

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

841

3835

1.46

22.47

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

494

2001

1.64

22.40

1.3

0.6

1.4

u/ml

2.07

220

829

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

197

3.23

22.32

2.5

3.5

42.7

41.5

umol/l

0.19

163

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

379

1429

1.76

22.31

2.4

2.6

731.7

1097.7

u/ml

3.24

374

1412

(3000060) B lymphocytes [#/volume] in Blood

229

728

2.09

22.30

2.5

2.0

194.1

667.9

e6/l

0.75

149

368

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

262

879

1.98

22.09

1.1

95.0

91.7

0.58

121

443

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

492

1999

1.64

22.06

4.0

3.9

—

(3029075) Extractable nuclear Ab panel - Serum

233

749

2.07

22.05

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

575

2428

1.58

22.02

3.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

269

914

1.96

21.89

1.1

111.7

107.3

0.93

245

826

(3022621) pH of Urine by Test strip

3045

16735

1.22

21.80

3.1

2.7

—

(3023419) Bacteria identified in Sputum by Culture

624

2694

1.54

21.70

2.7

2.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

350

1300

1.79

21.68

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

150

403

2.47

21.56

1.9

1.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

159

441

2.39

21.38

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

309

1109

1.85

21.38

1.8

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

270

927

1.94

21.34

3.1

2.8

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

280

975

1.91

21.24

2.3

2.0

28.6

29.5

0.45

270

924

(3047007) Chlamydophila sp Ab [Presence] in Serum

911

4264

1.42

21.20

1.3

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

269

925

1.93

21.17

2.3

2.0

153.5

162.3

0.66

258

876

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

104

232

2.98

21.16

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

105

236

2.95

21.10

1.1

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1024

4901

1.39

20.99

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

272

945

1.91

20.78

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

311

1129

1.83

20.77

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1421

7192

1.32

20.30

3.9

3.2

0.3

0.4

u/ml

1.84

830

4085

(3028433) Virus identified in Specimen by Culture

236

789

1.99

20.15

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

1154

5670

1.36

20.15

2.2

2.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

272

962

1.88

19.74

1.1

130.5

457.6

ng/l

1.70

233

(3004809) Band form neutrophils/100 leukocytes in Blood

803

3729

1.43

19.56

3.0

3.3

1.4

1.5

0.32

633

2908

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

411

1649

1.66

19.42

1.6

1.5

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

166

494

2.23

19.11

1.1

2.5

5.3

u/ml

0.77

124

344

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

221

2.91

19.09

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

433

1770

1.63

19.04

1.1

1.2

1.1

ratio

0.02

130

649

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

361

1409

1.70

18.92

1.2

1.3

21.8

21.7

u/l

0.02

309

1217

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

135

369

2.43

18.80

1.4

1.3

0.2

nmol/l

0.01

100

252

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

147

3.39

18.77

1.4

8.2

13.1

pmol/l

0.62

122

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

110

272

2.68

18.70

1.3

1.4

52.2

55.6

0.26

150

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

577

2533

1.52

18.67

3.9

5.0

82.6

116.0

u/ml

0.63

155

815

(3042733) HLA Ab [Presence] in Serum

258

914

1.88

18.66

4.4

5.2

—

(3006270) Folate [Moles/volume] in Blood

450

1867

1.60

18.65

1.2

1.1

380.6

382.7

nmol/l

0.08

395

1622

(3010375) cycloSPORINE [Mass/volume] in Blood

304

1136

1.78

18.55

28.8

27.7

126.7

117.0

ug/l

0.74

248

960

(3000475) Leukocytes [#/volume] in Synovial fluid

1153

5753

1.34

18.23

1.7

1.6

14464.3

12445.8

e6/l

0.60

811

4229

(3024869) Neuronal Ab [Presence] in Serum

134

371

2.40

18.17

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

367

1456

1.68

18.14

1.2

1.3

90.0

82.7

u/l

0.57

321

1273

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

310

1174

1.75

18.10

1.9

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

310

1174

1.75

18.10

1.9

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

310

1174

1.75

18.10

1.9

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

310

1176

1.75

17.99

1.9

2.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

307

1164

1.75

17.86

1.2

1.1

3.5

4.0

iu/ml

0.47

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

145

420

2.29

17.81

1.4

1.6

5.9

5.8

nmol/l

0.10

137

404

(3035320) C reactive protein [Mass/volume] in Body fluid

436

1818

1.59

17.73

3.0

2.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

130

365

2.36

17.14

1.1

1.0

87.6

82.0

ug/l

0.67

110

296

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

327

1279

1.70

17.07

9.5

5.1

612.4

4592.8

u/ml

0.70

113

212

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

614

2784

1.47

17.03

2.8

3.3

6.2

7.5

nmol/l

0.24

586

2700

(3045462) Protein/Creatinine [Ratio] in Urine

214

2.82

17.00

5.3

5.4

62.9

51.9

g/mol

0.16

194

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

254

924

1.83

16.97

2.1

2.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

201

2.87

16.78

1.6

1.5

1.9

mg/l

0.32

124

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

306

1181

1.72

16.77

2.4

2.3

21.1

255.1

ug/l

1.82

292

1129

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

389

1600

1.62

16.76

1.2

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

237

848

1.86

16.69

1.1

1.2

5.8

u/ml

2.36

147

472

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

163

3.09

16.60

1.2

18.8

13.6

nmol/l

0.90

(3033923) Metanephrine [Moles/time] in 24 hour Urine

153

468

2.17

16.57

1.2

1.1

0.7

3.7

umol/24h

0.52

242

(4034850)

1525

8021

1.27

16.30

11.2

8.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

248

908

1.81

16.26

2.1

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

248

909

1.81

16.20

2.1

2.2

—

(3042631) Mycobacterium sp identified in Specimen

625

2874

1.45

16.15

2.6

2.5

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

176

575

2.03

16.13

1.3

107.7

106.3

0.21

168

546

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2681

14985

1.20

16.06

3.2

3.3

52.8

46.5

u/ml

0.23

2573

14516

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

143

433

2.19

15.90

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1247

6416

1.30

15.88

3.2

3.4

1.6

3.3

ratio

2.48

121

497

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

197

2.83

15.81

1.6

3.2

4.4

mg/l

0.83

123

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

197

2.83

15.81

1.6

1.9

2.4

mg/l

0.29

125

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

197

2.83

15.81

1.6

2.7

2.8

mg/l

0.07

131

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

197

2.83

15.81

1.6

2.6

3.2

mg/l

0.28

139

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

197

2.83

15.81

1.6

1.0

1.1

mg/l

0.08

127

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

197

2.83

15.81

1.6

1.7

2.2

mg/l

0.41

141

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

197

2.83

15.81

1.6

1.0

1.6

mg/l

0.72

116

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

197

2.83

15.81

1.6

2.0

mg/l

0.45

137

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

197

2.83

15.81

1.6

2.2

1.8

mg/l

0.28

116

(3049717) Cytology report of Urine Cyto stain

1495

7880

1.27

15.72

2.3

2.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1281

6625

1.29

15.69

3.3

3.5

46.8

71.5

mg/l

1.25

1033

5393

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

228

2.68

15.66

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

211

743

1.89

15.64

1.7

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

937

4641

1.34

15.63

1.3

3.3

3.7

ug/l

0.84

834

4168

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.23

15.58

5.9

3.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1278

6615

1.29

15.56

3.3

3.5

30.8

43.1

mg/l

4.10

1023

5396

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

168

550

2.03

15.34

1.1

1.2

90.5

88.2

0.20

168

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

128

376

2.26

15.31

1.6

1.3

801.5

107.4

ng/l

0.44

261

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

426

1832

1.55

15.26

1.1

6.5

8.3

iu/ml

0.90

509

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

247

922

1.78

15.24

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

364

1510

1.60

15.21

1.6

4.1

7.1

u/l

4.04

171

757

(3014133) Dog dander IgE Ab [Units/volume] in Serum

930

4633

1.34

14.95

1.1

4.5

4.3

u/ml

0.14

387

1796

(3013336) Amino acids [Identifier] in Serum or Plasma

6.41

14.94

2.4

3.6

—

(3044941) Cell count panel - Synovial fluid

762

3684

1.38

14.86

1.5

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

143

447

2.12

14.75

6.1

5.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

488

2191

1.48

14.32

1.2

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

261

1010

1.72

14.26

5.4

5.9

67.8

3800.6

mg/l

4.91

195

723

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

214

782

1.82

14.20

3.5

3.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

103

285

2.40

14.11

1.3

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

460

2052

1.49

13.94

1.3

1.2

56.4

49.8

u/ml

0.14

100

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

124

375

2.19

13.90

1.2

1.1

—

(3016228) CD19 cells/100 cells in Blood

265

1040

1.69

13.79

2.1

2.0

8.7

8.5

0.12

258

1019

(3018851) Theophylline [Moles/volume] in Serum or Plasma

130

3.11

13.55

1.9

1.6

49.2

48.4

umol/l

0.06

130

(3017354) Segmented neutrophils/100 leukocytes in Blood

498

2272

1.46

13.51

3.0

3.4

58.4

58.2

0.07

325

1490

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.89

13.46

4.4

2.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

167

573

1.93

13.45

1.1

1.3

2.0

u/ml

—

(40768441) Liver Pathology biopsy report

420

1854

1.51

13.42

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1210

6347

1.27

13.31

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

259

1021

1.68

13.28

2.1

1.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

942

4786

1.31

13.26

1.6

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

446

1999

1.48

13.24

1.3

1.2

70.9

65.1

u/ml

0.16

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

447

2006

1.48

13.19

1.3

1.2

61.3

43.8

u/ml

0.70

158

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

308

1272

1.61

13.19

1.1

98.1

96.9

0.28

243

1016

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

357

1527

1.55

13.18

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

214

2.57

13.17

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

140

455

2.04

13.12

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

119

3.18

13.09

1.8

1.5

198.1

163.9

ug/g

0.58

106

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.92

13.00

4.1

2.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

225

859

1.74

12.95

2.0

1.6

46454.3

24267.1

u/ml

0.24

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

189

2.67

12.94

2.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

161

554

1.93

12.89

1.1

73.0

77.5

0.45

160

(3024932) HLA-DR beta [Type]

235

910

1.72

12.87

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

157

537

1.94

12.79

1.3

1.2

384.4

291.9

pmol/l

0.99

109

411

(3024471) HLA-A [Type]

239

932

1.70

12.77

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

864

4361

1.32

12.77

1.1

6.4

4.7

u/ml

0.85

383

1784

(3041806) Other cells [#/volume] in Blood by Manual count

310

1299

1.59

12.53

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

274

1115

1.63

12.48

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

315

1328

1.58

12.42

1.2

10.9

12.7

u/ml

0.09

127

(40761539) Cells [Type] in Urine sediment by Light microscopy

163

571

1.90

12.40

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

957

4922

1.29

12.34

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

307

1291

1.58

12.24

1.4

1.3

439.5

465.4

titre

0.03

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

112

344

2.16

12.16

2.1

2.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

425

1925

1.47

12.03

1.2

13.8

9.5

u/ml

0.27

135

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

282

1169

1.60

11.95

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

238

2.40

11.86

2.0

1.9

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

128

419

2.03

11.82

2.4

2.7

31.6

74.6

mg/l

1.75

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

310

1319

1.56

11.78

1.1

1672.2

1455.9

miu/ml

2.45

310

1319

(3021788) Differential panel - Synovial fluid

876

4482

1.30

11.77

1.6

1.5

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

272

2.29

11.76

1.0

0.8

2.4

u/ml

0.80

202

(3011841) English Walnut IgE Ab [Units/volume] in Serum

268

2.30

11.74

1.0

1.5

2.7

u/ml

0.38

204

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

102

306

2.21

11.74

1.4

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

280

1165

1.60

11.70

3.5

3.2

8.0

8.2

mg/l

0.18

230

930

(3005011) Chlamydia sp Ab [Titer] in Serum

110

341

2.14

11.70

1.7

1.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

192

2.56

11.66

1.2

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

4.25

11.65

1.0

0.3

0.7

u/ml

0.73

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

574

2763

1.38

11.62

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

962

4992

1.28

11.61

3.3

3.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

298

1262

1.57

11.57

1.4

1.3

64.3

75.3

titre

0.26

103

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

145

502

1.92

11.46

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

837

4276

1.30

11.39

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

222

877

1.68

11.38

2.7

2.2

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

153

2.73

11.27

1.5

34.1

34.6

0.03

107

(3003694) ABO and Rh group [Type] in Blood

13150

82421

1.08

11.15

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

544

4893

0.73

11.00

3.4

2.2

13.2

13.1

0.85

539

4829

(3045683) HLA typing for celiac disease panel - Blood or Tissue

400

1824

1.46

10.99

1.0

—

(4024509)

478

2254

1.41

10.95

1.7

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

205

803

1.70

10.87

2.1

1.8

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

168

2.61

10.82

1.1

1.4

3.1

u/ml

—

(37021550) Renin [Units/volume] in Plasma --upright

137

475

1.91

10.82

1.4

1.3

106.8

67.0

mu/l

0.35

107

365

(3044927) Protein electrophoresis panel - Urine

431

2000

1.43

10.81

1.3

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

190

730

1.73

10.80

5.8

6.8

25.1

25.0

mmol/l

0.16

177

656

(3034426) Prothrombin time (PT)

234

952

1.63

10.75

1.3

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

226

912

1.65

10.72

1.1

1.0

7.7

11.8

u/ml

1.06

116

(3002256) Pathology report gross observation

5747

34801

1.11

10.69

1.2

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

125

423

1.96

10.59

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

221

890

1.65

10.58

1.1

—

(3000330) Specific gravity of Urine by Test strip

2118

12034

1.17

10.55

3.6

3.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

255

1066

1.59

10.51

2.9

2.7

137.7

141.8

au/ml

0.05

139

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

134

2.77

10.32

1.5

1.6

11.2

13.2

0.26

102

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

153

2.64

10.31

4.0

1.9

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

4.37

10.29

1.6

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

335

1496

1.49

10.26

1.5

25.2

22.3

u/ml

0.42

271

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

637

3181

1.33

10.25

1.2

1.1

2.0

2.2

iu/ml

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

399

1847

1.44

10.17

1.8

1.4

60.0

72.3

umol/l

3.78

169

(3020123) Porphyrins [Interpretation] in Serum or Plasma

139

2.72

10.16

1.2

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

308

1355

1.51

10.15

1.2

1.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

114

381

1.99

10.03

1.1

0.2

0.3

u/ml

0.28

240

(3008037) Lactate [Moles/volume] in Venous blood

905

4750

1.27

10.03

3.5

2.8

1.5

mmol/l

0.36

887

4648

(3010370) Gastrin [Moles/volume] in Serum or Plasma

112

372

2.00

10.03

1.6

1.8

77.1

52.3

pmol/l

0.28

316

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

245

2.25

10.00

1.0

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

286

1243

1.53

9.98

1.2

1.1

96.1

81.7

u/l

1.12

229

1005

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

286

1244

1.53

9.94

1.2

1.1

32.4

21.6

u/l

0.96

214

979

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

160

2.57

9.94

1.0

0.2

2.4

u/ml

1.47

126

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

566

2791

1.35

9.93

2.1

2.2

32.4

32.6

0.42

559

2772

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

145

2.65

9.88

1.2

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

149

2.63

9.86

1.0

0.3

0.6

u/ml

0.44

139

(3051339) Copper [Moles/volume] in Blood

108

2.95

9.86

1.2

16.4

16.6

umol/l

0.08

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1182

6407

1.23

9.84

1.3

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

117

2.83

9.62

1.2

1.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

293

2.11

9.59

1.0

0.1

0.2

u/ml

0.52

172

(3013945) Hepatitis B virus e Ab [Presence] in Serum

144

2.63

9.54

1.5

—

(4015189)

146

540

1.79

9.51

2.5

2.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

149

2.58

9.40

1.0

1.1

7.7

9.7

u/l

0.44

149

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

105

350

1.99

9.34

2.4

2.0

—

(3052592) Norovirus Ag [Presence] in Stool

113

388

1.93

9.26

1.2

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

143

531

1.79

9.21

1.7

1.6

0.4

ug/l

0.27

361

(44806071)

106

357

1.97

9.18

1.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

315

1425

1.47

9.12

1.5

1.4

11.9

12.7

u/l

1.31

305

1377

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

142

529

1.78

9.06

1.1

—

(3037756) Immunofixation for Serum or Plasma

831

4377

1.26

9.00

1.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

726

3761

1.28

9.00

1.1

1.0

0.4

u/ml

0.03

170

754

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

152

1680

0.60

8.92

1.2

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

228

968

1.56

8.89

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

241

2.17

8.86

2.9

2.5

0.9

1.5

mmol/l

1.70

176

(21491868) Cryoglobulin [Mass/volume] in Serum

212

887

1.59

8.80

1.3

1.2

0.6

0.5

g/l

—

(3020491) Glucose [Moles/volume] in Blood

404

1927

1.39

8.78

1.7

1.6

6.7

6.5

mmol/l

0.71

308

1414

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

147

2.53

8.73

1.0

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

136

2.58

8.64

1.1

1.2

25.1

21.4

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

3.77

8.62

1.1

1.2

280.7

418.6

pmol/l

0.54

(3027974) Hepatitis B virus e Ag [Presence] in Serum

152

2.49

8.62

1.5

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.88

8.55

1.5

0.0

0.1

u/l

0.73

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

215

2.22

8.51

1.0

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.96

8.51

1.1

468.4

330.0

u/l

0.35

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

541

2717

1.32

8.47

1.1

—

(3045424) Erythrocytes [Presence] in Urine

842

4477

1.25

8.44

1.6

1.4

—

(3036603) Volume of Urine

358

1685

1.41

8.43

1.5

1.7

1772.7

1928.1

0.76

382

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

272

1216

1.49

8.40

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

225

966

1.55

8.39

3.7

3.9

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

123

2.64

8.35

1.1

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1664

9460

1.17

8.31

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1663

9454

1.17

8.31

1.4

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

112

2.72

8.29

1.4

1.3

1.6

1.9

0.08

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

5600

34271

1.09

8.29

1.5

1.4

—

(3033942) Copper [Moles/time] in 24 hour Urine

105

2.78

8.23

1.2

1.3

1.0

umol/24h

0.00

(3013762) Body weight Measured

2.89

8.22

1.1

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1659

9440

1.17

8.20

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

265

1185

1.48

8.18

1.6

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1654

9415

1.17

8.14

1.4

—

(3018133) Calcium [Moles/volume] in Urine

111

397

1.86

8.12

2.0

2.7

2.8

mmol/l

0.08

103

355

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

318

1.96

8.10

1.7

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

293

1342

1.45

8.03

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

266

1199

1.47

7.92

1.6

1.5

—

(4146454)

473

2355

1.33

7.90

2.7

2.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

289

1326

1.45

7.86

1.8

1.6

2.3

2.6

u/field

0.24

206

950

(3020393) Adenovirus Ag [Presence] in Stool

250

2.07

7.79

1.3

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1002

5479

1.22

7.77

2.5

123.7

99.4

ug/min

0.70

601

3365

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

109

394

1.84

7.74

1.6

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

266

1207

1.46

7.67

1.2

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1757

10099

1.16

7.65

1.4

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

298

1.96

7.59

1.1

—

(3016750) Collection duration of Urine

292

1352

1.43

7.58

2.2

520.4

495.3

min

4.57

223

1038

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

294

1.96

7.55

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

831

4477

1.23

7.46

1.1

2.9

u/ml

0.04

320

2388

(40757373) Influenza virus identified in Isolate

110

405

1.80

7.39

1.9

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

534

2734

1.30

7.35

1.1

—

(3049233) Organic acids panel - Urine

7.96

7.28

1.1

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

239

2.05

7.27

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

458

2307

1.32

7.12

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

180

2.21

7.09

1.0

—

(40768446) Kidney Pathology biopsy report

237

1070

1.47

7.06

1.9

1.7

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.70

7.00

2.0

2.9

2.0

1.9

mu/l

0.06

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

243

2.02

6.98

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1121

8779

0.84

6.97

1.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

675

3586

1.25

6.92

1.3

34.0

33.0

u/l

0.06

590

3132

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

347

1.84

6.87

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

191

832

1.52

6.77

1.8

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1188

6688

1.18

6.77

1.5

1.4

128.9

125.0

pmol/l

0.09

1157

6529

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

3.72

6.76

1.0

0.0

0.1

u/ml

0.30

(3020876) Protein [Mass/time] in 24 hour Urine

381

1885

1.34

6.72

2.1

2.0

0.8

1.1

g/24h

0.38

120

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

167

708

1.57

6.69

1.6

9.4

8.8

ug/l

0.73

167

708

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1373

7835

1.17

6.63

1.4

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

361

1.80

6.62

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3997

24339

1.10

6.60

3.5

4.2

20.0

25.1

ug/l

0.55

3131

19176

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

111

2.51

6.56

1.0

0.2

0.1

u/ml

0.33

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

234

1071

1.45

6.54

3.0

3.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

191

2.12

6.53

1.0

0.4

0.9

u/ml

0.81

104

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

242

1.97

6.41

1.2

1.1

1.6

3.2

umol/24h

0.56

242

(3051593) INR in Capillary blood by Coagulation assay

199

889

1.49

6.30

5.5

10.9

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.70

6.29

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

208

939

1.47

6.26

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.83

6.26

1.1

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

131

2.33

6.17

1.1

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

4.97

6.16

1.2

1.1

—

(3004451) EKG impression Narrative

224

1032

1.44

6.08

1.4

1.2

—

(4035726)

3719

22660

1.09

6.07

1.5

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.79

6.04

1.1

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

104

2.49

6.01

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

232

2154

0.71

5.98

1.2

1.3

1.4

1.5

g/l

0.59

(3010838) Calcium [Moles/time] in 24 hour Urine

262

1247

1.39

5.95

1.6

4.7

5.8

mmol/24h

0.83

100

(3038515) Glucose [Moles/volume] in Venous blood

817

4505

1.21

5.93

3.7

2.9

7.2

7.4

mmol/l

1.39

802

4422

(3005033) Fetal Nuchal fold Thickness US

1332

7659

1.16

5.87

1.4

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

411

2099

1.30

5.87

1.9

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

241

1.93

5.86

1.0

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

126

2.32

5.85

1.8

2.1

18.8

19.3

mmol/l

0.07

103

(3012898) Urea [Moles/volume] in Urine

237

1.93

5.82

1.7

1.5

164.2

176.3

mmol/l

0.34

214

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

140

2.23

5.72

1.1

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

193

2.03

5.70

1.1

1.0

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.83

5.69

1.0

307.7

175.3

pmol/l

0.69

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

150

646

1.54

5.69

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

101

394

1.70

5.68

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1805

10621

1.13

5.68

1.5

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

137

2.23

5.61

1.2

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

936

7295

0.85

5.59

1.4

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

367

1.72

5.55

2.9

2.3

—

(3024263) Appearance of Synovial fluid

253

1215

1.38

5.49

1.9

1.8

—

(3003129) Base excess in Capillary blood by calculation

125

521

1.59

5.47

1.6

1.7

1.0

0.4

mmol/l

0.88

116

491

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

118

485

1.61

5.47

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

183

2.03

5.45

1.0

0.2

2.2

u/ml

1.86

117

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

355

1.72

5.40

1.4

1.5

101497.7

273384.2

nmol/l

0.66

308

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1327

7680

1.15

5.39

1.4

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

523

2786

1.25

5.35

1.3

1.4

11.9

mmol/l

0.00

170

547

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

163

2.08

5.27

1.0

21.1

16.9

u/ml

0.16

135

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

292

1.77

5.10

1.0

1.1

0.1

0.7

u/ml

0.97

157

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

299

1.75

4.99

1.0

1.1

0.7

3.7

u/ml

0.78

162

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

176

2.00

4.97

3.0

2.8

101.2

423.6

pmol/l

0.38

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

190

1.95

4.95

1.4

1.3

1.6

ml/s/173m2

0.26

120

(40765089) Chromosome analysis panel - Blood by G-banded

219

1047

1.39

4.93

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

331

1686

1.30

4.91

2.1

1.7

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

358

1843

1.29

4.90

1.4

28.7

32.8

nmol/l

1.78

320

1709

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.23

4.90

1.2

1.0

1.8

2.8

1.17

(3010144) Erythrocytes [#/volume] in Synovial fluid

422

2220

1.26

4.86

1.4

65236.9

112677.0

e6/l

1.23

303

1523

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

185

861

1.43

4.86

1.7

118.2

131.8

au/ml

0.16

106

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

387

1.65

4.85

5.0

5.1

47.6

43.5

ug/min

0.22

296

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.67

4.83

1.2

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

342

1.69

4.83

3.1

2.6

14.9

ml/dl

0.01

322

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

129

2.16

4.82

1.1

1.4

1.2

u/field

0.58

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.48

4.80

1.0

1.1

0.2

g/l

1.64

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

224

1081

1.38

4.78

2.1

2.0

8.5

9.6

mg/l

1.91

178

865

(3020356) Listeria sp identified in Specimen by Organism specific culture

193

1.92

4.76

1.2

1.1

—

(3032641) Amino acids panel - Urine

5.21

4.73

1.2

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.03

4.65

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

224

1.84

4.59

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

144

648

1.47

4.54

1.4

1.2

—

(4094501)

1243

7260

1.14

4.49

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.39

4.49

1.0

1.1

2.1

0.9

u/field

0.47

(37019676) Renin [Units/volume] in Plasma --supine

3.15

4.48

1.1

1.0

78.5

64.1

mu/l

0.09

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.51

4.47

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

400

2116

1.26

4.44

3.0

63.3

51.6

mg/l

0.35

279

1493

(3004775) Volume in Urine collected for unspecified duration

347

1808

1.27

4.38

2.4

2.3

686.6

669.8

0.32

263

1273

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

383

1.61

4.37

1.1

2.9

8.6

pmol/l

0.69

(3033705) Calcium.ionized [Moles/volume] in Venous blood

471

2553

1.22

4.21

2.8

2.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.28

4.21

1.4

1.5

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

133

602

1.47

4.12

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

133

602

1.47

4.12

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

133

602

1.47

4.12

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

133

602

1.47

4.12

1.1

—

(36303858) Crystals [Presence] in Urine

3.32

4.09

1.2

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.78

4.08

1.0

2.3

0.4

u/ml

0.40

(3036071) Salmonella sp Ab [Titer] in Serum

191

925

1.37

4.07

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

388

2069

1.24

4.06

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.93

4.02

1.1

1.3

79.0

56.8

e6/l

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

274

1.69

4.02

1.0

1.1

0.1

0.6

u/ml

1.38

153

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1441

8559

1.12

4.00

3.0

3.6

4740.4

1561.7

u/ml

0.34

1208

7379

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

222

1105

1.33

3.97

1.5

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

122

2.07

3.97

1.0

1.1

35.3

65.6

u/l

1.74

(3050129) First trimester maternal screen panel - Serum or Plasma

2015

12189

1.10

3.95

1.5

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

132

2.01

3.89

1.1

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

221

1105

1.33

3.85

1.5

—

(3017704) Immunofixation for Urine

229

1151

1.32

3.85

1.8

1.7

—

(3006462) Nitrate [Presence] in Urine

247

1255

1.31

3.84

3.3

2.8

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.36

3.83

1.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

199

1.80

3.82

1.1

47.8

31.2

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

199

1.80

3.82

1.1

25.3

25.0

u/ml

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

414

1.54

3.77

2.2

2.4

6.8

7.6

mmol/l

1.04

243

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.40

3.70

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1028

6016

1.14

3.68

1.8

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

168

1.86

3.67

1.1

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

374

2013

1.23

3.64

1.1

3.3

2.7

u/ml

0.12

129

525

(40768793) Breast Pathology biopsy report

1064

6248

1.13

3.62

1.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

169

1.84

3.61

2.6

3.1

23.8

10.5

—

(3044009) aPTT.lupus sensitive (LA screen)

253

1.68

3.59

1.3

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

425

2323

1.21

3.57

1.6

31.0

33.5

0.69

269

1448

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

289

1.63

3.57

1.1

1.6

—

53.3

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

114

2.04

3.55

1.2

1.3

1528.2

1116.5

u/l

0.10

105

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

415

1.52

3.55

3.8

6.8

68.7

71.9

0.60

326

(3006567) Chloride [Moles/time] in 24 hour Urine

2.89

3.54

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

5.97

3.52

1.1

1.0

18.6

13.9

umol/l

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

171

1.82

3.49

1.1

1.7

1.0

u/ml

0.29

123

(3043410) Blood group antigens tested for on Red Blood Cells

140

663

1.40

3.47

1.9

1.6

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.47

3.47

4.2

5.1

8.1

6.3

mg/l

0.22

(21494890) Protein electrophoresis panel - 24 hour Urine

408

2229

1.22

3.46

2.1

2.2

—

(3045177) Copper [Moles/volume] in Urine

2.95

3.44

1.0

1.1

0.2

0.6

umol/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

813

4710

1.15

3.42

3.2

3.5

390.0

904.2

u/ml

1.47

727

4301

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

193

965

1.33

3.41

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

215

1092

1.31

3.40

2.1

59.3

84.1

ug/min

0.40

240

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

135

640

1.40

3.34

2.2

2.6

98.6

106.6

ng/l

0.26

322

(3008536) Aspergillus sp Ab [Presence] in Serum

106

481

1.46

3.32

2.1

2.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.18

3.28

1.0

1.1

194.4

285.3

nmol/l

2.15

(4211845)

264

1385

1.26

3.27

3.2

2.8

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

100

2.06

3.25

1.0

0.2

0.0

u/ml

0.59

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.44

3.25

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

111

511

1.44

3.24

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

147

1.85

3.22

1.3

1.1

—

(3024316) Viscosity of Plasma

110

1.99

3.19

1.7

1.6

1.5

mpas

0.30

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

461

2572

1.19

3.17

1.9

2.0

24.0

24.5

ug/l

0.06

453

2518

(3007916) DNA double strand Ab [Titer] in Serum

358

1.52

3.12

1.3

130.6

156.4

titre

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

137

661

1.37

3.09

1.8

2.0

43.2

30.8

u/l

0.43

120

602

(3049242) von Willebrand panel - Platelet poor plasma

2.15

3.08

1.4

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

242

1269

1.27

3.04

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

349

1906

1.22

3.03

2.1

1.9

2.2

2.3

u/field

0.14

175

828

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

329

1.53

3.02

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

156

1.79

2.97

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

176

1.73

2.96

1.2

1.3

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

124

1.87

2.88

1.1

1.3

—

438.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

101

469

1.43

2.87

2.2

5.7

80.8

53.7

u/l

0.35

192

(3036005) Urine sediment comments by Light microscopy Narrative

3.31

2.84

1.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.02

2.84

11.5

8.5

—

(3033799) Differential panel - Peritoneal fluid

126

611

1.37

2.80

2.0

1.8

—

(3042628) Porphyrins [Moles/volume] in Urine

5.80

2.79

1.1

1.0

—

(36304079) Mucus [Presence] in Urine sediment

5.80

2.79

1.0

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

140

693

1.34

2.73

1.4

55.7

52.6

0.41

118

601

(3002523) Influenza virus A Ag [Presence] in Specimen

882

5223

1.12

2.72

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

264

1.56

2.69

3.0

2.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1307

9472

0.91

2.64

1.5

1.6

—

(3000012) Reticulocyte production index

229

1216

1.25

2.64

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

137

680

1.34

2.64

1.3

1.2

39.1

40.4

g/l

0.56

366

(3003740) Influenza virus B Ag [Presence] in Specimen

880

5227

1.12

2.59

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

429

1.42

2.59

1.3

1.4

27.3

27.5

g/l

0.03

344

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

134

1.78

2.57

3.7

4.7

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

144

1.75

2.56

1.1

3.2

2.6

u/l

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

231

1.58

2.54

1.0

1.1

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.14

2.50

1.0

0.0

0.1

u/ml

0.43

(3013293) Extractable nuclear Ab [Presence] in Serum

405

1.42

2.49

1.7

1.6

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.69

2.45

1.0

0.1

0.3

u/ml

—

(3019174) dRVVT (LA screen)

244

1.55

2.44

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

267

1.52

2.38

2.4

2.1

0.6

0.7

u/field

0.38

267

(3023487) Leukocytes [#/volume] in Peritoneal fluid

145

739

1.30

2.37

2.4

1.9

617.3

3646.2

e6/l

1.50

100

500

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.01

2.34

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

119

1.78

2.32

8.8

9.3

696.0

244.5

e6/l

0.49

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

301

1.48

2.32

3.4

2.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.88

2.32

1.9

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

157

812

1.28

2.30

2.5

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

170

1.64

2.28

1.7

1.3

349.3

321.0

umol/24h

0.38

170

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

126

634

1.32

2.27

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.14

2.26

8.8

8.3

—

(3000219) Insulin receptor Ab [Presence] in Serum

6.63

2.26

1.0

—

(3012565) Volume of 24 hour Urine

236

1284

1.22

2.24

2.2

1943.8

2006.0

0.32

218

1162

(3015350) Toxocara sp Ab [Presence] in Serum

2.65

2.21

1.1

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.65

2.21

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.65

2.21

1.9

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.65

2.21

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.65

2.21

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.65

2.21

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.65

2.21

2.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.53

2.21

1.9

4.4

—

(3013466) aPTT in Blood by Coagulation assay

182

1.60

2.21

1.1

34.9

36.8

1.37

157

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.21

2.19

9.6

8.4

48.8

40.9

0.53

(3050794) Legionella sp Ab [Presence] in Serum

219

1.54

2.19

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

306

1712

1.19

2.17

6.5

6.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.31

2.14

1.0

1.1

84.7

98.5

nmol/24h

0.44

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

536

3136

1.13

2.11

1.6

53.7

55.1

0.34

334

2023

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

3.87

2.10

1.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

3.87

2.10

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

127

648

1.30

2.10

2.3

1.8

4195.9

12242.3

e6/l

1.48

340

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

262

1451

1.20

2.10

1.9

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.94

2.09

3.0

3.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1709

12114

0.93

2.07

2.1

1.8

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

104

517

1.33

2.07

1.3

1.2

45.1

44.8

mg/l

0.00

358

(3012989) Citrate [Moles/time] in 24 hour Urine

2.09

2.06

1.7

1.3

1.8

2.3

mmol/24h

0.85

(1761482) Bacteria [#/volume] in Urine by Culture

964

5841

1.10

2.02

4.7

3.6

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

429

1.36

2.00

1.2

1.4

39.8

186.7

titre

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.85

1.99

1.1

1.2

1.4

1.1

u/field

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.60

1.98

1.1

149.1

144.3

mmol/24h

0.10

(3014599) Egg white IgE Ab [Units/volume] in Serum

351

2005

1.16

1.97

1.1

1.0

3.4

2.6

u/ml

0.21

106

465

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

336

1.40

1.93

2.5

2.7

65.4

74.9

pmol/l

0.20

291

(21494567) Legionella sp IgM Ab [Presence] in Serum

179

1.56

1.90

1.2

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

742

4456

1.11

1.89

3.7

3.5

33.3

38.9

u/ml

0.66

706

4304

(3011335) Digoxin [Mass/volume] in Serum or Plasma

178

0.48

1.87

2.5

2.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

327

1.40

1.87

1.8

1.7

1.6

1.7

mg/l

0.22

273

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.81

1.87

1.3

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

204

0.52

1.86

1.2

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

171

1.55

1.80

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

225

1.47

1.79

1.3

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

347

1.38

1.79

2.1

1.5

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.12

1.78

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.34

1.77

1.6

1.3

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.62

1.76

1.0

55.0

21.8

umol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

160

862

1.23

1.75

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

400

2332

1.14

1.73

1.5

4145.0

2111.6

e6/l

1.37

307

1658

(40761995) Spermatozoa Progressive [#/volume] in Semen

113

950

0.79

1.73

3.5

3.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.09

1.73

1.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

113

949

0.79

1.72

7.0

6.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

333

1919

1.15

1.71

2.1

1.9

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.21

1.71

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

390

1.34

1.70

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

328

1.37

1.69

2.3

2.6

—

(44786800) Granulocytes/100 leukocytes in Body fluid

213

1.46

1.65

1.2

1.3

23.8

23.2

0.04

163

(3000285) Sodium [Moles/volume] in Blood

274

1.40

1.64

1.3

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

145

1.55

1.58

1.0

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.74

1.54

1.2

1.1

0.1

g/l

0.58

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

109

572

1.26

1.54

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

109

573

1.26

1.52

1.2

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

190

1.47

1.51

1.0

1.1

11.4

7.5

u/ml

0.45

136

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

109

574

1.26

1.50

1.2

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

124

663

1.24

1.50

1.3

1.4

59.7

63.4

0.58

101

547

(3027035) Albumin [Mass/time] in 24 hour Urine

229

1.42

1.49

1.5

1.3

178.5

330.6

mg/24h

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

219

1239

1.17

1.48

1.5

5.6

4.0

0.53

293

(3036782) Glucose [Moles/volume] in Pleural fluid

327

1906

1.14

1.47

1.3

6.3

mmol/l

0.02

300

1776

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

208

1.43

1.46

1.1

25.0

21.4

u/l

0.36

138

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

275

1.37

1.46

1.3

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

315

1834

1.14

1.45

1.1

1.0

0.7

0.8

u/ml

0.15

226

(3026692) Albumin [Mass/volume] in Peritoneal fluid

495

1.27

1.44

1.7

1.3

12.5

14.2

g/l

0.82

391

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.72

1.44

1.0

0.1

0.2

u/ml

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

221

1.41

1.40

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.93

1.36

1.3

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

173

1353

0.85

1.36

2.0

4.0

3.7

ug/l

0.10

145

1203

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.21

1.34

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

3.01

1.31

1.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

3.01

1.31

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

369

2729

0.90

1.30

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

1.84

1.29

1.6

1.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.70

1.28

1.2

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2916

18620

1.04

1.26

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

332

1962

1.12

1.25

1.9

1.8

3.6

3.5

mg/l

0.08

309

1879

(3009871) Measles virus Ab [Titer] in Serum

182

1035

1.17

1.21

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

300

1767

1.13

1.21

1.3

638.1

450.7

u/l

0.76

280

1685

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

1.20

0.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

170

1312

0.86

1.18

2.1

2.5

2.4

ug/l

0.10

138

1107

(3010937) Rubella virus Ab [Presence] in Serum

196

1.39

1.16

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

209

1.36

1.11

1.0

0.1

1.1

u/ml

0.69

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.32

1.11

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.61

1.09

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

542

1.21

1.05

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

172

1.39

1.04

4.7

5.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

150

1.41

1.03

1.2

114.7

108.0

ug/l

0.09

(3007456) Orange IgE Ab [Units/volume] in Serum

1.66

1.01

1.1

1.0

0.1

0.2

u/ml

0.36

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

367

2671

0.91

1.01

1.4

1.5

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.69

1.01

1.5

1.1

—

(3044007) Cell count panel - Peritoneal fluid

109

606

1.19

0.99

2.3

1.9

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

129

1.44

0.99

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

104

821

0.84

0.99

1.6

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

301

1.28

0.99

1.3

1.9

1.5

mmol/l

0.17

193

(40758047) Lysozyme [Mass/volume] in Pleural fluid

174

1.37

0.99

1.2

1.1

10.0

10.2

mg/l

0.04

158

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.86

0.99

2.6

2.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

146

1.41

0.98

1.4

22.2

21.8

mmol/l

0.16

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

180

1.36

0.98

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.61

0.98

1.1

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.63

0.97

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

175

1014

1.14

0.96

2.7

3.0

—

(3012441) Differential panel - Pleural fluid

333

2006

1.10

0.95

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

153

1.39

0.94

1.3

1.1

—

(3041184) Isoniazid [Presence] in Urine

1.93

0.94

2.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

166

962

1.14

0.92

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

377

1.23

0.90

12.2

5.5

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.84

0.89

1.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

424

2594

1.08

0.88

1.5

1.4

34.3

33.7

g/l

0.43

382

2345

(40758292) HTLV I+II Ab panel - Serum

493

1.20

0.87

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

133

1.40

0.87

3.9

3.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.83

0.86

1.1

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.77

0.83

1.5

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.77

0.83

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

146

1.36

0.82

1.4

—

(3047189) Immunofixation for 24 hour Urine

172

1011

1.13

0.81

2.1

1.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

348

2123

1.09

0.80

1.5

50454.9

44728.6

e6/l

0.17

231

1228

(3001019) Free T4 and TSH panel - Serum or Plasma

2592

17688

0.97

0.80

1.7

1.6

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

113

1.41

0.79

1.1

1.0

—

(3045788) Cell count panel - Pleural fluid

303

1838

1.09

0.79

1.6

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

142

1.35

0.77

1.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.21

0.77

1.2

1.1

30.6

31.3

nmol/24h

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

242

1.26

0.75

1.0

1.1

—

(3035880) pH of Pleural fluid

178

1054

1.12

0.75

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

120

1.38

0.75

1.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

604

3772

1.06

0.75

1.8

1.6

—

(3003157) Bacteria [#/volume] in Mother's milk

0.55

0.74

6.7

6.8

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

2.07

0.74

1.0

0.0

u/ml

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

237

1.26

0.74

1.1

—

(3034614) HLA Ag [Interpretation]

1.53

0.74

1.7

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.61

0.72

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

162

1.31

0.71

1.0

1.1

0.5

12.5

u/ml

0.49

(3022689) Creatine [Moles/volume] in Urine

126

734

1.14

0.71

1.4

1.5

—

(3002853) Influenza virus B Ab [Titer] in Serum

1.95

0.70

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.95

0.70

1.2

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

270

1.23

0.68

3.0

2.8

1.1

1.2

mg/l

0.23

173

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

175

1.29

0.68

1.1

6.7

17.4

iu/ml

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

273

1665

1.09

0.67

1.4

5.7

5.5

mmol/l

1.60

256

1576

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.56

0.65

1.0

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

136

1.32

0.63

1.1

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

393

0.83

0.63

4.6

5.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

376

1.18

0.63

1.4

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

297

1.21

0.63

1.1

1.5

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

131

1.32

0.61

2.0

1.9

18.4

18.2

0.01

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.53

0.60

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

379

1.17

0.59

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

373

1.17

0.58

1.2

1.7

1.8

mmol/l

0.22

222

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.73

0.58

1.0

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.73

0.58

1.2

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

394

2455

1.06

0.58

1.4

1.3

133.9

112.3

pmol/l

0.12

151

720

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

174

1.26

0.57

6.0

6.1

—

(3018291) Platelet Ab [Presence] in Serum

1.52

0.54

1.1

—

(40763590) HLA-DQ beta [Type]

105

1.33

0.53

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.42

0.52

1.0

1.1

75.5

70.4

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

283

0.82

0.52

1.1

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

571

1.13

0.52

1.3

1.4

3.0

2.3

0.34

479

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

521

1.13

0.52

2.5

2.6

—

(3007700) Barley IgE Ab [Units/volume] in Serum

147

1.26

0.51

1.0

1.1

0.2

10.5

u/ml

0.51

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

105

0.69

0.51

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

383

0.85

0.51

1.7

1.2

6.5

7.1

mmol/l

0.55

111

(40760410) HLA-B [Type] by High resolution

106

1.31

0.51

1.0

—

(40760409) HLA-A [Type] by High resolution

106

1.31

0.51

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

275

1.18

0.49

1.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

418

2921

0.95

0.49

1.6

7.9

7.5

mmol/l

2.22

250

1706

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

172

1.23

0.49

2.0

41.9

62.2

1.82

109

(46236302) HLA-C [Type] by High resolution typing

107

1.30

0.48

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

178

0.78

0.47

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

114

682

1.11

0.47

1.1

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

103

758

0.90

0.46

1.2

—

(3013862) HLA-DP [Type]

108

1.29

0.46

1.0

—

(4133840)

119

868

0.91

0.45

1.2

—

(3022670) pH of Venous cord blood

1.47

0.44

1.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.40

0.42

2.3

2.1

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.51

0.41

1.6

1.5

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

294

1.15

0.40

1.3

1.4

8.5

13.0

0.91

150

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

1.40

0.40

1.0

1.1

6.6

7.1

kpa

0.32

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

225

1401

1.06

0.39

1.2

1.3

12.9

13.9

u/l

0.41

205

1289

(44806420)

558

1.10

0.39

2.0

2.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

591

1.10

0.38

1.3

3.5

3.3

mmol/l

0.40

550

(21494434) Karyotype in Bone marrow

317

1998

1.05

0.38

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

130

1.22

0.37

1.0

1.1

—

(3006598) pH of Arterial cord blood

1.38

0.36

1.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.31

0.35

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

382

0.88

0.34

2.0

2.3

4.3

4.0

ug/l

0.10

134

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.26

0.34

1.0

0.0

0.2

u/ml

0.80

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

399

1.11

0.34

1.0

—

(3015183) Erythrocyte sedimentation rate

259

1635

1.05

0.31

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

170

1.17

0.31

1.1

1.2

19.0

17.7

g/l

0.48

153

(3046861) Legionella sp Ag [Presence] in Urine

127

1.20

0.31

1.2

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

245

1.14

0.30

1.2

1.3

5.5

6.5

mmol/l

0.57

122

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.29

0.30

1.0

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.29

0.30

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.30

0.30

1.1

1.2

20.9

30.2

mg/l

1.46

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.25

0.29

1.0

1.1

602.9

2255.1

titre

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

550

1.08

0.29

2.1

1.7

1.5

3.8

ug/l

1.51

335

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

260

1.12

0.27

1.3

32.7

327.1

u/l

0.99

186

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

336

1.10

0.27

1.1

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

103

636

1.07

0.27

1.3

40.9

0.00

437

(3037556) Urate [Mass/volume] in Serum or Plasma

111

690

1.07

0.25

1.3

—

(3025315) Body weight

218

1.13

0.25

4.3

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.27

0.23

1.2

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

5.7

—

(3025311) HLA-B [Type]

0.00

0.22

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(4038314)

272

0.90

0.21

1.2

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.4

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

125

0.85

0.21

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

402

0.92

0.20

6.3

7.4

—

(40768806) Pleura Pathology biopsy report

316

2031

1.03

0.20

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

665

4321

1.02

0.19

1.4

1.3

7.2

7.0

mmol/l

0.94

478

3098

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

144

0.87

0.18

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.23

0.17

1.0

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

470

1.06

0.16

1.4

25.2

23.2

0.23

397

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.17

0.15

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

303

1960

1.02

0.15

1.3

1.2

—

(3014891) Appearance of Pleural fluid

227

1.08

0.14

2.2

1.6

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

277

0.93

0.13

1.6

1.5

112.8

121.3

ug/l

0.19

224

(3045142) Bone marrow Pathology biopsy report

399

2692

0.98

0.12

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

704

4609

1.01

0.11

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

539

0.96

0.11

9.3

8.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

114

1.10

0.11

18.1

12.9

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

114

1.10

0.11

1.1

1.0

0.1

0.5

u/ml

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

134

1.09

0.10

1.2

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

402

1.04

0.08

3.2

2.7

3087.2

1780.7

u/l

0.54

363

(3003577) Lead [Moles/volume] in Blood

238

0.95

0.08

1.2

1.5

0.2

umol/l

0.10

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

660

0.97

0.07

1.4

1.3

—

(4281824)

436

2917

0.99

0.06

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

610

0.98

0.05

9.2

8.7

—

(40758358) Immune stain study

114

0.93

0.05

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

496

0.98

0.05

1.2

1.3

59.1

222.5

ug/l

2.57

260

(3035611) Eosinophils/100 leukocytes in Synovial fluid

154

0.95

0.05

1.7

1.8

0.7

0.6

0.11

120

(3048879) Bone marrow aspiration report

101

657

1.02

0.04

2.1

1.9

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

112

1.07

0.04

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

362

1.03

0.04

3.0

3.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

139

1.05

0.03

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

313

2090

0.99

0.03

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

544

3623

1.00

0.03

3.2

3.1

0.8

nmol/l

0.49

404

2830

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

199

1.03

0.02

4.7

2.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

847

5600

1.00

0.02

4.1

3.0

21.8

26.1

mg/l

2.92

522

3493

(4212803)

200

1.03

0.02

1.1

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

104

0.96

0.01

1.0

0.0

1.0

u/ml

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

1.07

0.01

1.4

1.2

4.9

5.3

mg/l

—

(3001729) Color of Synovial fluid

189

0.98

0.00

1.6

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

123

0.97

0.00

1.0

0.2

u/ml

0.01

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.04

0.00

1.1

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

365

1.00

0.00

7.5

8.5

0.4

umol/l

0.13

336

(3044336) Cobalt [Moles/volume] in Urine

1.00

0.00

3.4

2.4

34.8

25.7

nmol/l

0.29

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.03

0.00

5.0

5.5

0.2

mmol/l

0.14

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

237

1.01

0.00

1.3

1.4

69.5

72.2

0.19

202

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.90

0.00

1.4

1.2

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.7

—

4.7

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

1.7

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.92

0.00

1.2

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.90

0.00

1.4

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.90

0.00

1.3

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.95

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint KRA_PSY_ANXIETY_EXMORE and mortality.

Females

Parameter	HR [95% CI]	p-value
KRA_PSY_ANXIETY_EXMORE	1.89 [1.7, 2.09]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 18891 out of 236874 females with KRA_PSY_ANXIETY_EXMORE died.

Males

Parameter	HR [95% CI]	p-value
KRA_PSY_ANXIETY_EXMORE	2.194 [1.99, 2.42]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 15452 out of 142433 males with KRA_PSY_ANXIETY_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have KRA_PSY_ANXIETY_EXMORE.

N-year risk	Females	Males
1	0.16%	0.351%
5	0.819%	2.365%
10	2.079%	6.204%
15	4.01%	11.899%
20	7.188%	19.14%

Relationships between endpoints

↥

Index endpoint: KRA_PSY_ANXIETY_EXMORE – Anxiety disorders, excluding more controls

GWS hits: 33

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Anxiety disorders, excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints